2011-2016 - Winnipeg Regional Health Authority · management of reportable ... Communicable Disease Coordinators: public health nursing leadership, ... Amebiasis, WHR (2011-2016)

0

The Epidemiology of Communicable Diseases in the Winnipeg Health Region

communicable diseases

2011-2016 PUBLISHED OCTOBER 2017

Population Health Surveillance Team Population and Public Health Program

1 WRHA THE EPIDEMIOLOGY OF COMMUNICABLE DISEASES IN THE WINNIPEG HEALTH REGION

PU

BLISHED Someday

The Epidemiology of Communicable Diseases in

the Winnipeg Health Region

Population Health Surveillance Team

Population and Public Health

Program, WRHA

ACKNOWLEDGEMENTS

This report details the descriptive

epidemiology of select communicable

diseases in the Winnipeg Health Region.

Special gratitude is extended to the following

individuals:

Public Health Nurses: investigation and management of reportable communicable diseases, including detailed collection of and entry of surveillance data within iPHIS.

Communicable Disease Coordinators: public health nursing leadership, direction and oversight regarding the collection of surveillance data

Medical Officer of Health/Team Manager: public health clinical leadership and oversight

FOR FURTHER INFORMATION

For comments or inquiries concerning the material in this publication, contact [email protected].

Suggested Citation: Winnipeg Regional Health Authority, Population Health Surveillance Team. The Epidemiology of Communicable Diseases in the Winnipeg Health Region, 2011-2016. Winnipeg, 2017

mailto:[email protected]

WRHA THE EPIDEMIOLOGY OF COMMUNICABLE DISEASES IN THE WINNIPEG HEALTH REGION 2

THE WINNIPEG HEALTH REGION (WHR)

• The largest health region in the province of Manitoba with a population of 743,397 in 2014, more than half of the total provincial population.

• Includes the capital city of Winnipeg, and the rural municipalities of East St. Paul and West St. Paul.

• For planning and management purposes, the WHR is divided into 12 community areas.

• The Winnipeg Regional Health Authority (WRHA) is responsible for the delivery of acute care, public health and other community services to the residents of the WHR.

• In 2012, the Churchill Health Region became an operating division of the WRHA; however, residents of Churchill are not included in this surveillance report.


TABLE OF CONTENTS TABLE OF CONTENTS ....................................................................................................................... 3

TABLES ......................................................................................................................................... 4 FIGURES ....................................................................................................................................... 8

EXECUTIVE SUMMARY ................................................................................................................... 11 INTRODUCTION ............................................................................................................................. 12 METHODS ...................................................................................................................................... 12

DATA SOURCE AND CASE DEFINITIONS .................................................................................... 12 INCLUSION/EXCLUSION CRITERIA ............................................................................................. 13 VARIABLE DEFINITIONS ............................................................................................................. 13 STATISTICAL METHODS ............................................................................................................. 13 LIMITATIONS ............................................................................................................................. 14

RESULTS ......................................................................................................................................... 15 ENTERIC, FOOD, AND WATERBORNE DISEASES ............................................................................ 16

AMEBIASIS ................................................................................................................................. 19 CAMPYLOBACTERIOSIS ............................................................................................................. 27 CRYPTOSPORIDIOSIS ................................................................................................................. 35 GIARDIASIS ................................................................................................................................ 39 LISTERIOSIS ................................................................................................................................ 47 SALMONELLOSIS........................................................................................................................ 49 SHIGELLOSIS .............................................................................................................................. 57 TYPHOID FEVER ......................................................................................................................... 60 VEROTOXIGENIC E.COLI ............................................................................................................ 61

RESPIRATORY AND DIRECT CONTACT DISEASES ........................................................................... 69 BLASTOMYCOSIS ....................................................................................................................... 71 CREUTZFELDT-JAKOB DISEASE .................................................................................................. 71 MENINGOCOCCAL INVASIVE DISEASE ....................................................................................... 71 INVASIVE PNEUMOCOCCAL ...................................................................................................... 73

VACCINE PREVENTABLE DISEASES ................................................................................................. 81 DIPHTHERIA ............................................................................................................................... 83 HAEMOPHILUS INFLUENZAE NON-SEROTYPE B INVASIVE DISEASE ......................................... 83 HEPATITIS B ............................................................................................................................... 84 MUMPS ..................................................................................................................................... 87 PERTUSSIS ................................................................................................................................. 95 RUBELLA .................................................................................................................................. 103

VECTORBORNE AND ZOONOTIC DISEASES .................................................................................. 104 ANAPLASMOSIS ....................................................................................................................... 106 BRUCELLOSIS ........................................................................................................................... 106 LYME ........................................................................................................................................ 107 MALARIA ................................................................................................................................. 115 WEST NILE VIRUS .................................................................................................................... 123

EMERGING INFECTIOUS DISEASES .............................................................................................. 124 Zika Virus ................................................................................................................................. 124

APPENDIX A – Common and technical names of reportable diseases under The Manitoba Public Health Act .................................................................................................................................... 125


TABLES AND FIGURES

TABLES

TABLE 1: Number and crude rate of cases, select reportable diseases, WHR, 2011-2016........................................................................................................................................... 15 TABLE 2: Frequency, crude and age-standardized rates (per 100,000 people), enteric, food, and waterborne diseases, by community area, WHR (2011-2016) ........................ 17 TABLE 3: Frequency, crude and age-standardized rates (per 100,000 people), Amebiasis, WHR (2011-2016).............................................................................................................. 20 TABLE 4: Frequency and age-specific rates (per 100,000 people), Amebiasis, by age group, WHR (2016) ........................................................................................................... 22 TABLE 5: Frequency and age-specific rates (per 100,000 people), Amebiasis, by age group, WHR (2011-2015) .................................................................................................. 24 TABLE 6: Frequency and proportion, Amebiasis, by month, WHR (2011-2016) .............. 25 TABLE 7: Frequency, crude and age-standardized rates (per 100,000 people), Amebiasis, by community area, WHR (2011-2016) ............................................................................ 26 TABLE 8: Frequency, crude and age-standardized rates (per 100,000 people), Campylobacteriosis, WHR (2011-2016) ............................................................................ 28 TABLE 9: Frequency and age-specific rates (per 100,000 people), Campylobacteriosis, by age group, WHR (2016) ..................................................................................................... 30 TABLE 10: Frequency and age-specific rates (per 100,000 people), Campylobacteriosis, by age group, WHR (2011-2015)....................................................................................... 32 TABLE 11: Frequency and proportion, Campylobacteriosis, by month, WHR (2011-2016)........................................................................................................................................... 33 TABLE 12: Frequency, crude and age-standardized rates (per 100,000 people), Campylobacteriosis, by community area, WHR (2011-2016) ........................................... 34 TABLE 13: Frequency and crude rates (per 100,000 people), Cryptosporidiosis, WHR (2011-2016) ....................................................................................................................... 35 TABLE 14: Frequency and age-specific rates (per 100,000 people), Cryptosporidiosis, by age group, WHR (2011-2016) ........................................................................................... 36 TABLE 15: Frequency and proportion, Cryptosporidiosis, by month, WHR (2011-2016) 37 TABLE 16: Frequency and crude rates (per 100,000 people), Cryptosporidiosis, by community area, WHR (2011-2016) ................................................................................. 37 TABLE 17: Frequency, crude and age-standardized rates (per 100,000 people), Giardiasis, WHR (2011-2016).............................................................................................................. 40 TABLE 18: Frequency and age-specific rates (per 100,000 people), Giardiasis, by age group, WHR (2016) ........................................................................................................... 42 TABLE 19: Frequency and age-specific rates (per 100,000 people), Giardiasis, by age group, WHR (2011-2015) .................................................................................................. 44 TABLE 20: Frequency and proportion, Giardiasis, by month, WHR (2011-2016) ............. 45 TABLE 21: Frequency, crude and age-standardized rates (per 100,000 people), Giardiasis, by community area, WHR (2011-2016) ............................................................................ 46 TABLE 22: Frequency, Listeriosis, WHR (2011-2016) ........................................................ 47


TABLE 23: Frequency, crude and age-standardized rates (per 100,000 people), Salmonellosis, WHR (2011-2016) ...................................................................................... 50 TABLE 24: Frequency and age-specific rates (per 100,000 people), Salmonellosis, by age group, WHR (2016) ........................................................................................................... 52 TABLE 25: Frequency and age-specific rates (per 100,000 people), Salmonellosis, by age group, WHR (2011-2015) .................................................................................................. 54 TABLE 26: Frequency and proportion, Salmonellosis, by month, WHR (2011-2016) ...... 55 TABLE 27: Frequency, crude and age-standardized rates (per 100,000 people), Salmonellosis, by community area, WHR (2011-2016) .................................................... 56 TABLE 28: Frequency and crude rates (per 100,000 people), Shigellosis, WHR (2011-2016) ................................................................................................................................. 57 TABLE 29: Frequency and age-specific rates (per 100,000 people), Shigellosis, by age group, WHR (2011-2016) .................................................................................................. 58 TABLE 30: Frequency and proportion, Shigellosis, by month, WHR (2011-2016) ............ 59 TABLE 31: Frequency, Shigellosis, by community area, WHR (2011-2016) ...................... 59 Table 32: Frequency, Typhoid Fever, WHR (2011-2016) .................................................. 60 TABLE 33: Frequency, crude and age-standardized rates (per 100,000 people), Verotoxigenic E.coli, WHR (2011-2016) ............................................................................ 62 TABLE 34: Frequency and age-specific rates (per 100,000 people), Verotoxigenic, E.coli by age group, WHR (2016) ................................................................................................ 64 TABLE 35: Frequency and age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group, WHR (2011-2015 ........................................................................................ 66 TABLE 36: Frequency and proportion, Verotoxigenic E.coli, by month, WHR (2011-2016)........................................................................................................................................... 67 TABLE 37: Frequency, crude and age-standardized rates (per 100,000 people), Verotoxigenic E.coli, by community area, WHR (2011-2016) .......................................... 68 TABLE 38: Frequency, crude and age-standardized rates (per 100,000 people), diseases transmitted by direct contact or respiratory routes, by community area, WHR (2011-2016) ................................................................................................................................. 70 TABLE 39: Frequency and crude rates (per 100,000 people), Blastomycosis, WHR (2011-2016) ................................................................................................................................. 71 TABLE 40: Frequency, Creutzfeldt - Jakob disease, WHR (2011-2016) ............................ 71 TABLE 41: Frequency, Meningococcal Invasive Disease, WHR (2011-2016) .................... 71 TABLE 42: Frequency, crude and age-standardized rates (per 100,000 people), Invasive Pneumococcal, WHR (2011-2016) .................................................................................... 74 TABLE 43: Frequency and age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group, WHR (2016) ...................................................................... 76 TABLE 44: Frequency and age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group, WHR (2011-2015) ............................................................. 78 TABLE 45: Frequency and proportion, Invasive Pneumococcal, by community area, WHR (2011-2016) ....................................................................................................................... 79 TABLE 46: Frequency, crude and age-standardized rates (per 100,000 people), Invasive Pneumococcal, by community area, WHR (2011-2016) ................................................... 80


TABLE 47: Frequency, crude and age-standardized rates (per 100,000 people), vaccine preventable diseases, by community area, WHR (2011-2016) ........................................ 82 TABLE 48: Frequency, Diphtheria, WHR (2011-2016) ...................................................... 83 TABLE 49: Frequency, Haemophilus influenzae non-serotype B invasive disease, WHR (2011-2016) ....................................................................................................................... 83 TABLE 50: Frequency and crude rates (per 100,000 people), Hepatitis B, WHR (2011-2016) ................................................................................................................................. 84 TABLE 51: Frequency and age-specific rates (per 100,000 people), Hepatitis B, by age group, WHR (2011-2016) .................................................................................................. 85 TABLE 52: Frequency and proportion, Hepatitis B, by month, WHR (2011-2016) ........... 86 Table 53: Frequency, Hepatitis B, by community area, WHR (2011-2016) ...................... 86 TABLE 54: Frequency, crude and age-standardized rates (per 100,000 people), Mumps, WHR (2011-2016).............................................................................................................. 88 TABLE 55: Frequency and age-specific rates (per 100,000 people), Mumps, by age group, WHR (2016) ....................................................................................................................... 90 TABLE 56: Frequency and age-specific rates (per 100,000 people), Mumps, by age group, WHR (2011-2015).............................................................................................................. 92 TABLE 57: Frequency and proportion, Mumps, by month, WHR (2011-2016) ................ 93 TABLE 58: Frequency, crude and age-standardized rates (per 100,000 people), Mumps, by community area, WHR (2011-2016) ............................................................................ 94 TABLE 59: Frequency, crude and age-standardized rates (per 100,000 people), Pertussis, WHR (2011-2016).............................................................................................................. 96 TABLE 60: Frequency and age-specific rates (per 100,000 people), Pertussis, by age group, WHR (2016) ........................................................................................................... 98 TABLE 61: Frequency and age-specific rates (per 100,000 people), Pertussis, by age group, WHR (2011-2015) ................................................................................................ 100 TABLE 62: Frequency and proportion, Pertussis, by month, WHR (2011-2016) ............ 101 Table 63: Frequency, crude and age-standardized rates (per 100,000 people), Pertussis, by community area, WHR (2011-2016) .......................................................................... 102 TABLE 64: Frequency, Rubella, WHR (2011-2016) .......................................................... 103 TABLE 65: Frequency, crude and age-standardized rates (per 100,000 people) by community area, vectorborne and zoonotic diseases, WHR (2011-2016) ..................... 105 TABLE 66: Frequency, Anaplasmosis, WHR (2011-2016) ............................................... 106 TABLE 67: Frequency, Brucellosis, WHR (2011-2016) .................................................... 106 TABLE 68: Frequency, crude and age-standardized rates (per 100,000 people), Lyme, WHR (2011-2016)............................................................................................................ 108 TABLE 69: Frequency and age-specific rates (per 100,000 people), Lyme, by age group, WHR (2016) ..................................................................................................................... 110 TABLE 70: Frequency and age-specific rates (per 100,000 people), Lyme, by age group, WHR (2011-2015)............................................................................................................ 112 TABLE 71: Frequency and proportion, Lyme, by month, WHR (2011-2016) .................. 113 TABLE 72: Frequency, crude and age-standardized rates (per 100,000 people), Lyme, by community area, WHR (2011-2016) ............................................................................... 114


TABLE 73: Frequency, crude and age-standardized rates (per 100,000 people), Malaria, WHR (2011-2016)............................................................................................................ 116 TABLE 74: Frequency and age-specific rates (per 100,000 people), Malaria, by age group, WHR (2016) ..................................................................................................................... 118 TABLE 75: Frequency and age-specific rates (per 100,000 people), Malaria, by age group, WHR (2011-2015)............................................................................................................ 120 TABLE 76: Frequency and proportion, Malaria, by month, WHR (2011-2016) .............. 121 TABLE 77: Frequency, crude and age-standardized rates (per 100,000 people), Malaria, by community area, WHR (2011-2016) .......................................................................... 122 TABLE 78: Frequency and crude rates (per 100,000 people), West Nile Virus, WHR (2011-2016) ............................................................................................................................... 123


FIGURES

FIGURE 1: Age-standardized rates (per 100,000 people), enteric, food, and waterborne diseases, by community area, WHR (2011-2016) ............................................................. 16 FIGURE 2: Age-standardized rates (per 100,000 people), Amebiasis, WHR (2011-2016) 19 FIGURE 3: Age-specific rates (per 100,000 people), Amebiasis, by age group and gender, WHR (2016) ....................................................................................................................... 21 FIGURE 4: Age-specific rates (per 100,000 people), Amebiasis, by age group and gender, WHR (2011-2015).............................................................................................................. 23 FIGURE 5: Frequency, Amebiasis, by month, WHR (2016 vs. 2011-2015 mean) ............. 25 FIGURE 6: Age-standardized rates (per 100,000 people), Amebiasis, by community area, WHR (2011-2016).............................................................................................................. 26 FIGURE 7: Age-standardized rates (per 100,000 people), Campylobacteriosis, WHR (2011-2016) ....................................................................................................................... 27 FIGURE 8: Age-specific rates (per 100,000 people), Campylobacteriosis, by age group and gender, WHR (2016) .................................................................................................. 29 FIGURE 9: Age-specific rates (per 100,000 people), Campylobacteriosis, by age group and gender, WHR (2011-2015) ......................................................................................... 31 FIGURE 10: Frequency, Campylobacteriosis, by month, WHR (2016 vs. 2011-2015 mean)........................................................................................................................................... 33 FIGURE 11: Age-standardized rates (per 100,000 people), Campylobacteriosis, by community area, WHR (2011-2016) ................................................................................. 34 FIGURE 12: Age-standardized rates (per 100,000 people), Giardiasis, WHR (2011-2016)........................................................................................................................................... 39 FIGURE 13: Age-specific rates (per 100,000 people), Giardiasis, by age group and gender, WHR (2016) ....................................................................................................................... 41 FIGURE 14: Age-specific rates (per 100,000 people), Giardiasis, by age group and gender, WHR (2011-2015).............................................................................................................. 43 FIGURE 15: Frequency, Giardiasis, by month, WHR (2016 vs. 2011-2015 mean) ........... 45 FIGURE 16: Age-standardized rates (per 100,000 people), Giardiasis, by community area, WHR (2011-2016).............................................................................................................. 46 FIGURE 17: Age-standardized rates (per 100,000 people), Salmonellosis, WHR (2011-2016) ................................................................................................................................. 49 FIGURE 18: Age-specific rates (per 100,000 people), Salmonellosis, by age group and gender, WHR (2016) ......................................................................................................... 51 FIGURE 19: Age-specific rates (per 100,000 people), Salmonellosis, by age group and gender, WHR (2011-2015) ................................................................................................ 53 FIGURE 20: Frequency, Salmonellosis, by month, WHR (2016 vs. 2011-2015 mean) ...... 55 FIGURE 21: Age-standardized rates (per 100,000 people), Salmonellosis, by community area, WHR (2011-2016) .................................................................................................... 56 FIGURE 22: Age-standardized rates (per 100,000 people), Verotoxigenic E.coli, WHR (2011-2016) ....................................................................................................................... 61


FIGURE 23: Age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group and gender, WHR (2016) .................................................................................................. 63 FIGURE 24: Age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group and gender, WHR (2011-2015) ......................................................................................... 65 FIGURE 25: Frequency, Verotoxigenic E.coli, by month, WHR (2016 vs. 2011-2015 mean)........................................................................................................................................... 67 FIGURE 26: Age-standardized rates (per 100,000 people), Verotoxigenic E.coli, by community area, WHR (2011-2016) ................................................................................. 68 FIGURE 27: Age-standardized rates (per 100,000 people), diseases transmitted by direct contact and respiratory routes, by community area, WHR (2011-2016) ......................... 69 FIGURE 28: Age-standardized rates (per 100,000 people), Invasive Pneumococcal, WHR (2011-2016) ....................................................................................................................... 73 FIGURE 29: Age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group and gender, WHR (2016) ........................................................................................ 75 FIGURE 30: Age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group and gender, WHR (2011-2016) ............................................................................... 77 FIGURE 31: Frequency, Invasive Pneumococcal, by month, WHR (2016 vs. 2011-2015 mean) ................................................................................................................................ 79 FIGURE 32: Age-standardized rates (per 100,000 people), Invasive Pneumococcal, by community area, WHR (2011-2016) ................................................................................. 80 FIGURE 33: Age-standardized rates (per 100,000 people), vaccine preventable diseases, by community area, WHR (2011-2016) ............................................................................ 81 FIGURE 34: Age-standardized rates (per 100,000 people), Mumps, WHR (2011-2016) .. 87 FIGURE 35: Age-specific rates (per 100,000 people), Mumps, by age group and gender, WHR (2016) ....................................................................................................................... 89 FIGURE 36: Age-specific rates (per 100,000 people), Mumps, by age group and gender, WHR (2011-2015).............................................................................................................. 91 FIGURE 37: Frequency, Mumps, by month, WHR (2016 vs. 2011-2015 mean) ............... 93 FIGURE 38: Age-standardized rates (per 100,000 people), Mumps, by community area, WHR (2011-2016).............................................................................................................. 94 FIGURE 39: Age-standardized rates (per 100,000 people), Pertussis, WHR (2011-2016) 95 FIGURE 40: Age-specific rates (per 100,000 people), Pertussis, by age group and gender, WHR (2016) ....................................................................................................................... 97 FIGURE 41: Age-specific rates (per 100,000 people), Pertussis, by age group and gender, WHR (2011-2015).............................................................................................................. 99 FIGURE 42: Frequency, Pertussis, by month, WHR (2016 vs. 2011-2015 mean) ........... 101 FIGURE 43: Age-standardized rates (per 100,000 people), Pertussis, by community area, WHR (2011-2016)............................................................................................................ 102 FIGURE 44: Age-standardized rates (per 100,000 people), vectorborne and zoonotic diseases, by community area, WHR (2011-2016) ........................................................... 104 FIGURE 45: Age-standardized rates (per 100,000 people), Lyme, WHR (2011-2016).... 107 FIGURE 46: Age-specific rates (per 100,000 people), Lyme, by age group and gender, WHR (2016) ..................................................................................................................... 109


FIGURE 47: Age-specific rates (per 100,000 people), Lyme, by age group and gender, WHR (2011-2015)............................................................................................................ 111 FIGURE 48: Frequency, Lyme, by month, WHR (2016 vs. 2011-2015 mean) ................. 113 FIGURE 49: Age-standardized rates (per 100,000 people), Lyme, by community area, WHR (2011-2016)............................................................................................................ 114 FIGURE 50: Age-standardized rates (per 100,000 people), Malaria, WHR (2011-2016) 115 FIGURE 51: Age-specific rates (per 100,000 people), Malaria, by age group and gender, WHR (2016) ..................................................................................................................... 117 FIGURE 52: Age-specific rates (per 100,000 people), Malaria, by age group and gender, WHR (2011-2016)............................................................................................................ 119 FIGURE 53: Frequency, Malaria, by month, WHR (2016 vs. 2011-2015 mean) ............. 121 FIGURE 54: Age-standardized rates (per 100,000 people), Malaria, by community area, WHR (2011-2016)............................................................................................................ 122


EXECUTIVE SUMMARY This report, The epidemiology of communicable diseases in the

Winnipeg Health Region 2011-2016, provides a regional

surveillance summary of select infections/diseases listed as

reportable under The Manitoba Public Health Act (with the

exception of influenza, tuberculosis, and sexually transmitted

and blood-borne infections as they are reported elsewhere).

The report is divided into five broad disease categories (i)

Enteric, food, and waterborne diseases (ii) Respiratory and

direct contact diseases (iii) Vaccine preventable diseases, and

(iv) Vector-borne and zoonotic diseases, and iv) Emerging

infectious diseases. Within each section, diseases are presented

separately with the type of analysis based on the number of

cases reported in 2016. As this is a technical surveillance

report, results are limited to statistical tabulations by age, sex,

and geographical data.

This report contains the most current description of the broad

patterns of communicable diseases in the Winnipeg Health

Region and is intended to provide evidence to inform the

planning of programs and policies for prevention.


INTRODUCTION

This report focuses on communicable

diseases and infections that are notifiable in

Manitoba under The Public Health Act1 (with

the exception of influenza, tuberculosis, and

sexually transmitted and blood-borne

infections, which are reported elsewhere).

Communicable diseases (CD) are investigated

and managed by a team of Public Health

Nurses, Public Health Inspectors,

Communicable Disease Coordinators and

Medical Officers of Health/Team Managers,

and analyzed by Population Health

Surveillance epidemiologists, with the primary

goal of reducing the transmission and spread

of CDs, and ensuring public safety.

As the prevention, treatment, and

management of communicable diseases

remains a priority for the Winnipeg Regional

Health Authority (WRHA), epidemiologic

information at the regional level is essential

for program and planning purposes.

Therefore, this report provides the most up-

to-date information available on the

descriptive epidemiology of select

communicable diseases in the Winnipeg

Health Region (WHR).

1 http://www.gov.mb.ca/health/publichealth/act.html

METHODS

DATA SOURCE AND CASE DEFINITIONS

Case definitions, reporting requirements and

guidelines for case management and contact

investigation are outlined in the provincial

disease management protocols2. Laboratory

and clinical case reports are submitted by

laboratories and health care providers to

Manitoba Health; and subsequently referred

to Regional Health Authorities for follow-up.

Upon receipt of a referral, and for the

duration of follow-up, regional public health

nurses collect standardized case and contact

information through client interviews, and by

reviewing hospital and laboratory records.

Information collected on each client includes

sociodemographic information (e.g., birth

date, gender, address of residence) as well as

clinical information (e.g., results of microbial

testing). Data are entered into the regional

public health information system (iPHIS), a

Web-based application that facilitates

charting of information on patients with

select notifiable communicable diseases

(Appendix A) among residents of the WHR or

for clients whose care is managed by the

WHR.

2

http://www.gov.mb.ca/health/publichealth/cdc/protocol/index.h

tml, Assessed December 12, 2014

http://www.gov.mb.ca/health/publichealth/cdc/protocol/index.html

http://www.gov.mb.ca/health/publichealth/cdc/protocol/index.html


INCLUSION/EXCLUSION CRITERIA

All confirmed cases of select notifiable

communicable diseases reported among

residents of the WHR at the time of diagnosis

between January 1, 2011 and December 31,

2016 were included in the analysis.

Anaplasmosis and Babesiosis were added to

The Public Health Act on January 1, 2015 and

as such only have two years of data available.

Cases with unknown gender and those with a

missing or invalid postal code were excluded.

VARIABLE DEFINITIONS

Infections were assigned to a calendar year

based on epidate (defined as the earliest of

specimen collection date and date reported

to public health). Age of the client at the time

of infection was defined using birth date and

epidate, and age groups were assigned based

on standard convention. Infections were

assigned to community areas (CAs) using

postal code of residence at time of testing

and the 2014 Manitoba postal code

conversion file.

STATISTICAL METHODS

Annual crude rates of communicable diseases

were calculated using the corresponding

year’s mid-point WHR population as the

denominator. Population data were derived

from the Manitoba Health Insurance Registry

and provided (in electronic format) by

Manitoba Health. Population counts for 2015

and 2016 were not available at the time of

analysis; therefore, 2014 population counts

were used for all rate calculations involving

communicable diseases reported in 2015 and

2016.

Rates were directly age-standardized to the

2006 Canadian population (provided by

Statistics Canada) and 95% confidence

intervals were calculated using the Tiwari et

al.3 formula. All analyses, including mapping,

were completed using StataMP 13 (StataCorp,

College Station, TX).

Communicable diseases with less than or

equal to 5 cases reported in 2016 were not

analyzed in detail, but total case counts for

these diseases were included in Table 1, and

within overall case counts where applicable

(such as under category totals). For diseases

with less than or equal to 15 cases, graphical

analysis was not completed and standardized

rates were not calculated as small case counts

may result in unstable rates and decrease the

usefulness of any comparisons within or

between groups.

3 Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for

age-adjusted cancer rates. Stat Methods Med Res.

2006;15:547-569.


LIMITATIONS

There are a number of limitations to consider

when interpreting the findings. The

surveillance data used for this analysis do not

permit exploration of populations defined by

factors other than geography, age, and sex. As

a result, analyses exploring other variables

such as education, income or behavioural risk

factors could not be readily undertaken.

Due to different standardization methods and

the choice of standard populations, age-

standardized rates may differ from other

published reports. Rates for single years by

small geographic areas can result in rates

being calculated based on a small number of

cases. These rates are unstable and should be

interpreted with caution. Rates may be

influenced by changes in testing practices and

patterns over time. Sharp increases in rates

in a time period may due to disease

outbreaks, which are not highlighted in this

report.

The number of reported cases is a fraction of

the actual count as it is limited to those

individuals who seek medical attention and

who have samples submitted for testing.

Despite these limitations, this report provides

timely, important and quantifiable insights

into select communicable diseases in the

WHR population to inform the planning of

programs and policies for prevention.


RESULTS

2016 2011-2015

Category Disease No. Crude Rate No. Crude Rate

Enteric, Food, and Waterborne Diseases

Amebiasis 19 2.6 102 2.8

Campylobacteriosis 67 9.0 362 9.9

Cryptosporidiosis 10 1.3 75 2.1

Giardiasis 70 9.4 275 7.5

Listeriosis, invasive disease 2 - 12 0.3

Salmonellosis 136 18.3 529 14.5

Shigellosis 8 1.1 65 1.8

Typhoid Fever 5 - 21 0.6

Verotoxigenic E.coli infection 19 2.6 73 2.0

Respiratory and Direct Contact Diseases

Blastomycosis 8 1.1 1 -

Creutzfeldt-Jakob Disease 1 - 3 -

Meningococcal Invasive disease 3 - 5 -

Pneumococcal Disease, Invasive 46 6.2 342 9.4

Group B strep (neonatal) 1 - - -

Vaccine Preventable Diseases

Diphtheria 3 - 6 0.2 Haemophilus influenzae non-Serotype B Invasive Disease 4 - 29 0.8

Hepatitis B* 13 1.7 19 0.5

Mumps 89 12.0 12 0.3

Pertussis 36 4.8 36 1.0

Rubella 2 - 3 -

Vector-Borne and Zoonotic Diseases

Anaplasmosis 3 - 4 -

Brucellosis 1 - 2 -

Lyme Disease 17 2.3 45 1.2

Malaria 16 2.2 79 2.2

Q Fever 1 - 0 -

West Nile Virus 8 1.1 18 0.5

Emerging Infectious Diseases

Zika Virus 6 0.8 - -

Reportable diseases with zero cases in 2016 are not included in this report Rates were not calculated for cell counts less than 5; rate denominator is 100,000 people *includes acute infections only

TABLE 1: Number and crude rate of cases, select reportable diseases, WHR, 2011-2016


ENTERIC, FOOD, AND WATERBORNE DISEASES This section of the report provides an overview of select diseases that enter the body as a result of eating or drinking contaminated foods or liquids and result in gastrointestinal infection or intoxication. A total of 1,878 cases fell in this category between 2011 and 2016, with the highest infection rates in the Downtown (54.6/100,000 people) and River Heights (53.4/100,000 people) community areas (Figure 1; Table 2).

FIGURE 1: Age-standardized rates (per 100,000 people), enteric, food, and

waterborne diseases, by community area, WHR (2011-2016)


Number Crude Rate Age-Standardized

Rate 95%CI

Community area St. James 133 37.1 37.7 31.5 - 44.8 Assiniboine South 88 41.6 41.8 33.3 - 51.7 Fort Garry 255 51.2 50.8 44.7 - 57.4 St. Vital 159 38.4 38.3 32.5 - 44.7 St. Boniface 146 42.1 41.5 35.1 - 48.9 Transcona 77 33.7 33.4 26.3 - 41.8 River East 224 38.6 38.3 33.4 - 43.7 Seven Oaks 155 35.1 34.8 29.6 - 40.8 Inkster 69 33.9 32.0 24.9 - 40.6 Point Douglas 107 38.1 37.9 30.9 - 46.0 Downtown 284 58.1 54.6 48.4 - 61.4 River Heights 181 53.3 53.4 45.7 - 62.0 Total 1,878 42.8 42.3 40.4 - 44.3

TABLE 2: Frequency, crude and age-standardized rates (per 100,000 people), enteric, food, and waterborne diseases, by community area, WHR (2011-2016)



AMEBIASIS

FIGURE 2: Age-standardized rates (per 100,000 people), Amebiasis, WHR (2011-2016)


Total

Number Crude Rate Age-Standardized Rate 95%CI

2011 22 3.1 3.1 1.9 - 4.6 2012 27 3.7 3.8 2.5 - 5.6 2013 13 1.8 1.8 1.0 - 3.1 2014 22 3.0 3.0 1.9 - 4.6 2015 18 2.4 2.4 1.4 - 3.7 2016 19 2.6 2.5 1.5 - 3.9 Total 121 2.8 2.8 2.3 - 3.3

a) Females


2011 9 2.5 2.4 1.1 - 4.6 2012 11 3.0 3.1 1.6 - 5.6 2013 7 1.9 1.9 0.8 - 4.0 2014 9 2.4 2.5 1.1 - 4.7 2015 5 1.3 1.3 0.4 - 3.1 2016 8 2.1 2.1 0.9 - 4.2 Total 49 2.2 2.2 1.6 - 2.9

b) Males


2011 13 3.7 3.6 1.9 - 6.2 2012 16 4.5 4.6 2.6 - 7.4 2013 6 1.7 1.8 0.6 - 3.8 2014 13 3.6 3.6 1.9 - 6.2 2015 13 3.6 3.4 1.8 - 5.8 2016 11 3.0 2.9 1.5 - 5.3 Total 72 3.3 3.3 2.6 - 4.2

TABLE 3: Frequency, crude and age-standardized rates (per 100,000 people), Amebiasis, WHR

(2011-2016)


FIGURE 3: Age-specific rates (per 100,000 people), Amebiasis, by age group and gender,

WHR (2016)


a) Total

Number Age-Specific Rate 95%CI

Age group 0-4 1 2.4 0.1 - 13.4 5-9 2 4.8 0.6 - 17.5 10-19 1 1.1 0.0 - 6.2 20-29 7 6.3 2.5 - 13.0 30-39 3 2.9 0.6 - 8.4 40-49 2 2.0 0.2 - 7.2

0.0 - 5.3 0.0 - 7.3 0.0 - 7.4 1.5 - 7.0

50-59 1 1.0 60-69 1 1.3 70+ 1 1.3 Total 19 2.6

b) Females


Age group 0-4 0 0.0 0.0 - 18.3 5-9 1 4.9 0.1 - 27.5 10-19 1 2.3 0.1 - 12.9 20-29 4 7.3 2.0 - 18.6

0.0 - 10.6 0.1 - 11.1 0.0 - 7.0 0.0 - 9.2 0.0 - 8.3 0.9 - 4.2

30-39 1 1.9 40-49 1 2.0 50-59 0 0.0 60-69 0 0.0 70+ 0 0.0 Total 8 2.1

c) Males


Age group 0-4 1 4.7 0.1 - 26.2 5-9 1 4.7 0.1 - 26.4 10-19 0 0.0 0.0 - 8.0 20-29 3 5.3 1.1 - 15.6

0.5 - 14.0 0.1 - 11.1 0.0 - 10.7 0.1 - 15.3 0.1 - 18.2 1.5 - 5.4

30-39 2 3.9 40-49 1 2.0 50-59 1 1.9 60-69 1 2.8 70+ 1 3.3 Total 11 3.0

TABLE 4: Frequency and age-specific rates (per 100,000 people), Amebiasis, by age group,

WHR (2016)


FIGURE 4: Age-specific rates (per 100,000 people), Amebiasis, by age group and gender,

WHR (2011-2015)


a) Total


Age group 0-4 4 2.0 0.5 - 5.0 5-9 8 4.0 1.7 - 7.8 10-19 13 2.9 1.6 - 5.0 20-29 26 4.8 3.2 - 7.1 30-39 26 5.1 3.4 - 7.5 40-49 15 3.0 1.7 - 4.9 50-59 8 1.6 0.7 - 3.1 60-69 0 0.0 0.0 - 1.0 70+ 2 0.5 0.1 - 2.0 Total 102 2.8 2.3 - 3.4

b) Females


Age group 0-4 1 1.0 0.0 - 5.6 5-9 1 1.0 0.0 - 5.6 10-19 7 3.2 1.3 - 6.7 20-29 11 4.1 2.0 - 7.3 30-39 9 3.5 1.6 - 6.7 40-49 6 2.4 0.9 - 5.2 50-59 4 1.5 0.4 - 4.0 60-69 0 0.0 0.0 - 1.9 70+ 2 0.9 0.1 - 3.3 Total 41 2.2 1.6 - 3.0

c) Males


Age group 0-4 3 2.9 0.6 - 8.4 5-9 7 6.8 2.7 - 14.0 10-19 6 2.6 1.0 - 5.7 20-29 15 5.5 3.1 - 9.1 30-39 17 6.8 4.0 - 10.9 40-49 9 3.6 1.6 - 6.7 50-59 4 1.6 0.4 - 4.0 60-69 0 0.0 0.0 - 2.1 70+ 0 0.0 0.0 - 2.5 Total 61 3.4 2.6 - 4.4

TABLE 5: Frequency and age-specific rates (per 100,000 people), Amebiasis, by age group,

WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %

Month January 2 10.5 8 7.8 10 8.3 February 1 5.3 3 2.9 4 3.3 March 2 10.5 12 11.8 14 11.6 April 1 5.3 7 6.7 8 6.6 May 1 5.3 9 8.8 10 8.3 June 2 10.5 11 10.8 13 10.7 July 2 10.5 9 8.8 11 9.1 August 3 15.8 10 9.8 13 10.7 September 1 5.3 11 10.8 12 9.9 October 0 0.0 11 10.8 11 9.1 November 1 5.3 6 5.9 7 5.8 December 3 15.8 5 4.9 8 6.6

FIGURE 5: Frequency, Amebiasis, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 6: Frequency and proportion, Amebiasis, by month, WHR (2011-2016)



Community area St. James 2 0.6 0.7 0.1 - 2.4 Assiniboine South 1 0.5 0.5 0.0 - 2.7 Fort Garry 17 3.4 3.3 1.9 - 5.4 St. Vital 5 1.2 1.3 0.4 - 3.0 St. Boniface 5 1.4 1.4 0.5 - 3.4 Transcona 2 0.9 0.9 0.1 - 3.1 River East 17 2.9 3.1 1.8 - 4.9 Seven Oaks 25 5.7 5.6 3.6 - 8.3 Inkster 8 3.9 3.8 1.6 - 7.5 Point Douglas 6 2.1 2.1 0.8 - 4.5 Downtown 26 5.3 5.1 3.3 - 7.5 River Heights 7 2.1 1.9 0.8 - 4.0 Total 121 2.8 2.8 2.3 - 3.3

FIGURE 6: Age-standardized rates (per 100,000 people), Amebiasis, by community area, WHR (2011-

2016)

TABLE 7: Frequency, crude and age-standardized rates (per 100,000 people), Amebiasis, by

community area, WHR (2011-2016)


CAMPYLOBACTERIOSIS

FIGURE 7: Age-standardized rates (per 100,000 people), Campylobacteriosis, WHR (2011-

2016)


a) Total


2011 125 17.6 17.4 14.5 - 20.8 2012 74 10.3 10.2 8.0 - 12.8 2013 68 9.3 9.1 7.0 - 11.5 2014 50 6.7 6.5 4.8 - 8.6 2015 45 6.1 6.0 4.4 - 8.0 2016 67 9.0 8.9 6.9 - 11.3 Total 429 9.8 9.6 8.7 - 10.6

b) Females


2011 69 19.0 18.8 14.6 - 23.8 2012 37 10.1 9.7 6.8 - 13.4 2013 42 11.3 11.1 8.0 - 15.0 2014 26 6.9 6.7 4.4 - 9.9 2015 23 6.1 5.9 3.7 - 8.9 2016 37 9.8 9.7 6.8 - 13.4 Total 234 10.5 10.3 9.0 - 11.7

c) Males


2011 56 16.2 16.1 12.1 - 20.9 2012 37 10.5 10.4 7.3 - 14.4 2013 26 7.2 7.0 4.6 - 10.3 2014 24 6.6 6.4 4.1 - 9.5 2015 22 6.0 6.0 3.8 - 9.1 2016 30 8.2 8.1 5.4 - 11.5 Total 195 9.0 8.9 7.7 - 10.3

TABLE 8: Frequency, crude and age-standardized rates (per 100,000 people),

Campylobacteriosis, WHR (2011-2016)


FIGURE 8: Age-specific rates (per 100,000 people), Campylobacteriosis, by age group and gender,

WHR (2016)


a) Total


Age group 0-4 5 12.1 3.9 - 28.2 5-9 0 0.0 0.0 - 8.9 10-19 3 3.4 0.7 - 9.8 20-29 8 7.2 3.1 - 14.2 30-39 8 7.7 3.3 - 15.2 40-49 9 9.0 4.1 - 17.1 50-59 14 13.4 7.3 - 22.4 60-69 13 17.1 9.1 - 29.2 70+ 7 9.3 3.7 - 19.2 Total 67 9.0 7.0 - 11.4

b) Female


Age group 0-4 1 5.0 0.1 - 27.7 5-9 0 0.0 0.0 - 18.2 10-19 2 4.6 0.6 - 16.7 20-29 3 5.5 1.1 - 15.9 30-39 7 13.4 5.4 - 27.5 40-49 4 8.0 2.2 - 20.5 50-59 8 15.2 6.6 - 30.0 60-69 9 22.6 10.3 - 42.8 70+ 3 6.8 1.4 - 19.7 Total 37 9.8 6.9 - 13.5

c) Male


Age group 0-4 4 18.8 5.1 - 48.1 5-9 0 0.0 0.0 - 17.5 10-19 1 2.2 0.1 - 12.1 20-29 5 8.9 2.9 - 20.8 30-39 1 1.9 0.0 - 10.8 40-49 5 10.0 3.2 - 23.3 50-59 6 11.5 4.2 - 25.0 60-69 4 11.0 3.0 - 28.2 70+ 4 13.0 3.6 - 33.4 Total 30 8.2 5.5 - 11.7

TABLE 9: Frequency and age-specific rates (per 100,000 people), Campylobacteriosis, by age

group, WHR (2016)


FIGURE 9: Age-specific rates (per 100,000 people), Campylobacteriosis, by age group and

gender, WHR (2011-2015)


a) Total


Age group 0-4 22 10.8 6.7 - 16.3 5-9 10 5.0 2.4 - 9.1 10-19 22 4.9 3.1 - 7.5 20-29 71 13.2 10.3 - 16.6 30-39 43 8.5 6.2 - 11.5 40-49 52 10.3 7.7 - 13.5 50-59 65 12.6 9.7 - 16.1 60-69 39 10.7 7.6 - 14.6 70+ 38 10.3 7.3 - 14.2 Total 362 9.9 8.9 - 11.0

b) Female


Age group 0-4 11 11.0 5.5 - 19.7 5-9 6 6.1 2.2 - 13.2 10-19 14 6.5 3.5 - 10.9 20-29 38 14.2 10.0 - 19.5 30-39 18 7.1 4.2 - 11.2 40-49 28 11.1 7.3 - 16.0 50-59 35 13.5 9.4 - 18.8 60-69 22 11.5 7.2 - 17.5 70+ 25 11.4 7.4 - 16.9 Total 197 10.6 9.2 - 12.2

c) Male


Age group 0-4 11 10.5 5.3 - 18.8 5-9 4 3.9 1.1 - 9.9 10-19 8 3.5 1.5 - 6.9 20-29 33 12.2 8.4 - 17.1 30-39 25 10.0 6.5 - 14.7 40-49 24 9.5 6.1 - 14.1 50-59 30 11.7 7.9 - 16.7 60-69 17 9.8 5.7 - 15.6 70+ 13 8.7 4.7 - 15.0 Total 165 9.2 7.9 - 10.7

TABLE 10: Frequency and age-specific rates (per 100,000 people), Campylobacteriosis, by age

group, WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 10: Frequency, Campylobacteriosis, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 11: Frequency and proportion, Campylobacteriosis, by month, WHR (2011-2016)




FIGURE 11: Age-standardized rates (per 100,000 people), Campylobacteriosis, by community

area, WHR (2011-2016)

TABLE 12: Frequency, crude and age-standardized rates (per 100,000 people),

Campylobacteriosis, by community area, WHR (2011-2016)


CRYPTOSPORIDIOSIS

a) Total

Number Crude Rate

2011 9 1.3 2012 11 1.5 2013 7 1.0 2014 40 5.4 2015 8 1.1 2016 10 1.3 Total 85 1.9

b) Females

Number Crude Rate

2011 5 1.4 2012 7 1.9 2013 5 1.3 2014 18 4.8 2015 5 1.3 2016 2 0.5 Total 42 1.9

c) Males

Number Crude Rate

2011 4 1.2 2012 4 1.1 2013 2 0.6 2014 22 6.0 2015 3 0.8 2016 8 2.2 Total 43 2.0

TABLE 13: Frequency and crude rates (per 100,000 people), Cryptosporidiosis, WHR (2011-

2016)


a) Total

2016 2011-2015

Number Age-Specific Rate Number Age-Specific Rate

Age group 0-4 0 0.0 16 7.8 5-9 3 7.2 6 3.0 10-19 1 1.1 14 3.1 20-29 4 3.6 15 2.8 30-39 2 1.9 11 2.2 40-49 0 0.0 9 1.8 50-59 0 0.0 1 0.2 60-69 0 0.0 2 0.5 70+ 0 0.0 1 0.3 Total 10 1.3 75 2.1

b) Females


Age group 0-4 0 0.0 5 5.0 5-9 0 0.0 2 2.0 10-19 0 0.0 6 2.8 20-29 1 1.8 12 4.5 30-39 1 1.9 9 3.5 40-49 0 0.0 4 1.6 50-59 0 0.0 1 0.4 60-69 0 0.0 1 0.5 70+ 0 0.0 0 0.0 Total 2 0.5 40 2.2

c) Males


Age group 0-4 0 0.0 11 10.5 5-9 3 14.2 4 3.9 10-19 1 2.2 8 3.5 20-29 3 5.3 3 1.1 30-39 1 1.9 2 0.8 40-49 0 0.0 5 2.0 50-59 0 0.0 0 0.0 60-69 0 0.0 1 0.6 70+ 0 0.0 1 0.7 Total 8 2.2 35 2.0

TABLE 14: Frequency and age-specific rates (per 100,000 people), Cryptosporidiosis, by age

group, WHR (2011-2016)


Total No. %

Month

January 4 4.7 February 4 4.7 March 6 7.1 April 4 4.7 May 1 1.2 June 3 3.5 July 6 7.1 August 12 14.1 September 28 32.9 October 10 11.8 November 6 7.1 December 1 1.2

Number Crude Rate

Community area St. James 7 2.0 Assiniboine South 6 2.8 Fort Garry 13 2.6 St. Vital 16 3.9 St. Boniface 8 2.3 Transcona 5 2.2 River East 9 1.6 Seven Oaks 7 1.6 Inkster 1 0.5 Point Douglas 5 1.8 Downtown 4 0.8 River Heights 4 1.2 Total 85 1.9

TABLE 15: Frequency and proportion, Cryptosporidiosis, by month, WHR (2011-2016)

TABLE 16: Frequency and crude rates (per 100,000 people), Cryptosporidiosis, by community

area, WHR (2011-2016)



GIARDIASIS

FIGURE 12: Age-standardized rates (per 100,000 people), Giardiasis, WHR (2011-2016)


a) Total

Number Crude Rate Age-Standardized Rate

95%CI

2011 60 8.5 8.6 6.5 - 11.0 2012 59 8.2 8.3 6.3 - 10.7 2013 44 6.0 6.0 4.4 - 8.1 2014 50 6.7 6.7 5.0 - 8.9 2015 62 8.3 8.3 6.4 - 10.7 2016 70 9.4 9.3 7.3 - 11.8 Total 345 7.9 7.9 7.1 - 8.8

b) Female


95%CI

2011 28 7.7 8.1 5.4 - 11.7 2012 22 6.0 6.2 3.8 - 9.3 2013 10 2.7 2.7 1.3 - 5.0 2014 22 5.8 6.1 3.8 - 9.2 2015 17 4.5 4.6 2.7 - 7.4 2016 25 6.6 6.6 4.2 - 9.7 Total 124 5.5 5.7 4.7 - 6.8

c) Male


95%CI

2011 32 9.2 9.1 6.2 - 12.8 2012 37 10.5 10.4 7.3 - 14.3 2013 34 9.5 9.3 6.4 - 13.0 2014 28 7.7 7.3 4.8 - 10.6 2015 45 12.3 12.1 8.8 - 16.2 2016 45 12.3 12.1 8.8 - 16.2 Total 221 10.3 10.1 8.8 - 11.5

TABLE 17: Frequency, crude and age-standardized rates (per 100,000 people), Giardiasis,

WHR (2011-2016)


FIGURE 13: Age-specific rates (per 100,000 people), Giardiasis, by age group and gender,

WHR (2016)


a) Total


Age group 0-4 13 31.4 16.7 - 53.6 5-9 6 14.5 5.3 - 31.6 10-19 6 6.7 2.5 - 14.6 20-29 14 12.6 6.9 - 21.1 30-39 8 7.7 3.3 - 15.2 40-49 8 8.0 3.5 - 15.8 50-59 4 3.8 1.0 - 9.8 60-69 10 13.1 6.3 - 24.1 70+ 1 1.3 0.0 - 7.4 Total 70 9.4 7.3 - 11.9

b) Females


Age group 0-4 6 29.8 10.9 - 64.8 5-9 3 14.8 3.0 - 43.2 10-19 2 4.6 0.6 - 16.7 20-29 4 7.3 2.0 - 18.6 30-39 2 3.8 0.5 - 13.8 40-49 0 0.0 0.0 - 7.4 50-59 2 3.8 0.5 - 13.7 60-69 5 12.5 4.1 - 29.3 70+ 1 2.3 0.1 - 12.5 Total 25 6.6 4.3 - 9.8

c) Males


Age group 0-4 7 32.9 13.2 - 67.7 5-9 3 14.2 2.9 - 41.5 10-19 4 8.7 2.4 - 22.3 20-29 10 17.8 8.5 - 32.8 30-39 6 11.6 4.3 - 25.3 40-49 8 16.0 6.9 - 31.5 50-59 2 3.8 0.5 - 13.8 60-69 5 13.8 4.5 - 32.1 70+ 0 0.0 0.0 - 12.0 Total 45 12.3 9.0 - 16.5

TABLE 18: Frequency and age-specific rates (per 100,000 people), Giardiasis, by age group,

WHR (2016)


FIGURE 14: Age-specific rates (per 100,000 people), Giardiasis, by age group and gender,

WHR (2011-2015)


a) Total


Age group

0-4 72 35.2 27.6 - 44.3 5-9 48 23.8 17.5 - 31.5 10-19 28 6.3 4.2 - 9.1 20-29 30 5.6 3.8 - 7.9 30-39 35 6.9 4.8 - 9.6 40-49 26 5.1 3.4 - 7.5 50-59 16 3.1 1.8 - 5.0 60-69 17 4.7 2.7 - 7.5 70+ 3 0.8 0.2 - 2.4 Total 275 7.5 6.7 - 8.5

b) Females


Age group

0-4 26 26.0 17.0 - 38.1 5-9 19 19.3 11.6 - 30.1 10-19 12 5.5 2.9 - 9.7 20-29 9 3.4 1.5 - 6.4 30-39 11 4.3 2.2 - 7.7 40-49 9 3.6 1.6 - 6.7 50-59 6 2.3 0.9 - 5.0 60-69 6 3.1 1.2 - 6.9 70+ 1 0.5 0.0 - 2.5 Total 99 5.3 4.3 - 6.5

c) Males


Age group

0-4 46 44.0 32.2 - 58.7 5-9 29 28.1 18.8 - 40.4 10-19 16 7.0 4.0 - 11.3 20-29 21 7.8 4.8 - 11.9 30-39 24 9.6 6.1 - 14.3 40-49 17 6.7 3.9 - 10.7 50-59 10 3.9 1.9 - 7.2 60-69 11 6.3 3.2 - 11.3 70+ 2 1.3 0.2 - 4.9 Total 176 9.8 8.4 - 11.4

TABLE 19: Frequency and age-specific rates (per 100,000 people), Giardiasis, by age group,

WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 15: Frequency, Giardiasis, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 20: Frequency and proportion, Giardiasis, by month, WHR (2011-2016)



Community area

St. James 7 2.0 2.3 0.9 - 4.6 Assiniboine South 6 2.8 3.4 1.2 - 7.2 Fort Garry 13 2.6 2.5 1.3 - 4.4 St. Vital 16 3.9 4.0 2.3 - 6.5 St. Boniface 8 2.3 2.4 1.0 - 4.6 Transcona 5 2.2 2.1 0.7 - 4.9 River East 9 1.6 1.6 0.7 - 3.0 Seven Oaks 7 1.6 1.6 0.6 - 3.3 Inkster 1 0.5 0.4 0.0 - 2.6 Point Douglas 5 1.8 1.6 0.5 - 3.9 Downtown 4 0.8 0.7 0.2 - 1.9 River Heights 4 1.2 1.2 0.3 - 3.1 Total 85 1.9 1.9 1.5 - 2.4

FIGURE 16: Age-standardized rates (per 100,000 people), Giardiasis, by community area,

WHR (2011-2016)

TABLE 21: Frequency, crude and age-standardized rates (per 100,000 people), Giardiasis, by



LISTERIOSIS

Number

Year 2011 3 2012 3 2013 1 2014 2 2015 3 2016 2 Total 14

TABLE 22: Frequency, Listeriosis, WHR (2011-2016)



SALMONELLOSIS

FIGURE 17: Age-standardized rates (per 100,000 people), Salmonellosis, WHR (2011-2016)


a) Total


2011 88 12.4 12.2 9.8 - 15.1 2012 98 13.6 13.3 10.8 - 16.3 2013 120 16.4 16.2 13.4 - 19.4 2014 109 14.7 14.4 11.8 - 17.3 2015 114 15.3 15.0 12.4 - 18.0 2016 136 18.3 18.0 15.1 - 21.3 Total 665 15.1 14.9 13.8 - 16.1

b) Females


2011 49 13.5 13.1 9.7 - 17.3 2012 38 10.3 10.2 7.2 - 14.0 2013 55 14.8 14.5 10.9 - 18.9 2014 61 16.1 15.7 12.0 - 20.2 2015 63 16.7 16.2 12.4 - 20.7 2016 82 21.7 21.1 16.8 - 26.2 Total 348 15.6 15.2 13.6 - 16.9

c) Males


95%CI

2011 39 11.2 11.1 7.9 - 15.2 2012 60 17.0 16.7 12.7 - 21.5 2013 65 18.1 17.9 13.8 - 22.8 2014 48 13.1 12.9 9.5 - 17.1 2015 51 14.0 13.6 10.1 - 18.0 2016 54 14.8 14.5 10.9 - 19.0 Total 317 14.7 14.5 12.9 - 16.1

TABLE 23: Frequency, crude and age-standardized rates (per 100,000 people), Salmonellosis,

WHR (2011-2016)


FIGURE 18: Age-specific rates (per 100,000 people), Salmonellosis, by age group and gender, WHR

(2016)


a) Total


Age group 0-4 15 36.2 20.3 - 59.7 5-9 9 21.7 9.9 - 41.3 10-19 6 6.7 2.5 - 14.6 20-29 21 18.9 11.7 - 28.9 30-39 17 16.4 9.5 - 26.2 40-49 11 11.0 5.5 - 19.7 50-59 23 21.9 13.9 - 32.9 60-69 15 19.7 11.0 - 32.5 70+ 19 25.3 15.2 - 39.5 Total 136 18.3 15.3 - 21.6

b) Females


Age group 0-4 7 34.8 14.0 - 71.6 5-9 6 29.6 10.9 - 64.4 10-19 4 9.2 2.5 - 23.7 20-29 11 20.0 10.0 - 35.8 30-39 8 15.3 6.6 - 30.1 40-49 6 12.0 4.4 - 26.1 50-59 18 34.2 20.3 - 54.1 60-69 9 22.6 10.3 - 42.8 70+ 13 29.3 15.6 - 50.0 Total 82 21.7 17.3 – 26.9

c) Males


Age group 0-4 8 37.6 16.2 - 74.0 5-9 3 14.2 2.9 - 41.5 10-19 2 4.3 0.5 - 15.7 20-29 10 17.8 8.5 - 32.8 30-39 9 17.5 8.0 - 33.1 40-49 5 10.0 3.2 - 23.3 50-59 5 9.6 3.1 - 23.3 60-69 6 16.5 6.1 - 35.9 70+ 6 19.6 7.2 - 42.6 Total 54 14.8 11.1 - 19.3

TABLE 24: Frequency and age-specific rates (per 100,000 people), Salmonellosis, by age

group, WHR (2016)


FIGURE 19: Age-specific rates (per 100,000 people), Salmonellosis, by age group and gender,

WHR (2011-2015)


a) Total


Age group

0-4 53 25.9 19.4 - 33.9 5-9 28 13.9 9.2 - 20.0 10-19 49 11.0 8.1 - 14.5 20-29 107 19.9 16.3 - 24.0 30-39 60 11.9 9.1 - 15.3 40-49 49 9.7 7.2 - 12.8 50-59 76 14.8 11.6 - 18.5 60-69 55 15.1 11.4 - 19.6 70+ 52 14.1 10.6 - 18.6 Total 529 14.5 13.3 - 15.8

b) Females


Age group

0-4 19 19.0 11.4 - 29.7 5-9 9 9.1 4.2 - 17.3 10-19 21 9.7 6.0 - 14.8 20-29 62 23.1 17.7 - 29.6 30-39 26 10.2 6.7 - 15.0 40-49 27 10.7 7.0 - 15.5 50-59 43 16.6 12.0 - 22.4 60-69 26 13.6 8.9 - 20.0 70+ 33 15.1 10.4 - 21.2 Total 266 14.3 12.6 - 16.1

c) Males


Age group

0-4 34 32.5 22.5 - 45.5 5-9 19 18.4 11.1 - 28.8 10-19 28 12.2 8.1 - 17.6 20-29 45 16.6 12.1 - 22.2 30-39 34 13.6 9.4 - 19.0 40-49 22 8.7 5.4 - 13.1 50-59 33 12.9 8.9 - 18.1 60-69 29 16.7 11.2 - 23.9 70+ 19 12.8 7.7 - 20.0 Total 263 14.7 13.0 - 16.6

TABLE 25: Frequency and age-specific rates (per 100,000 people), Salmonellosis, by age

group, WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 20: Frequency, Salmonellosis, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 26: Frequency and proportion, Salmonellosis, by month, WHR (2011-2016)




FIGURE 21: Age-standardized rates (per 100,000 people), Salmonellosis, by community area,

WHR (2011-2016)

TABLE 27: Frequency, crude and age-standardized rates (per 100,000 people), Salmonellosis,

by community area, WHR (2011-2016)


SHIGELLOSIS

a) Total

Number Crude Rate

2011 14 2.0 2012 15 2.1 2013 14 1.9 2014 11 1.5 2015 11 1.5 2016 8 1.1 Total 73 1.7

b) Females

Number Crude Rate

2011 5 1.4 2012 4 1.1 2013 7 1.9 2014 4 1.1 2015 7 1.9 2016 6 1.6 Total 33 1.5

c) Males

Number Crude Rate

2011 9 2.6 2012 11 3.1 2013 7 1.9 2014 7 1.9 2015 4 1.1 2016 2 0.5 Total 40 1.9

TABLE 28: Frequency and crude rates (per 100,000 people), Shigellosis, WHR (2011-2016)


a) Total

2016 2011-2015


Age group 0-4 0 0.0 9 4.4 5-9 0 0.0 9 4.5 10-19 0 0.0 5 1.1 20-29 2 1.8 14 2.6 30-39 0 0.0 6 1.2 40-49 1 1.0 9 1.8 50-59 3 2.9 4 0.8 60-69 0 0.0 4 1.1 70+ 2 2.7 5 1.4 Total 8 1.1 65 1.8

b) Females


Age group 0-4 0 0.0 3 3.0 5-9 0 0.0 2 2.0 10-19 0 0.0 3 1.4 20-29 1 1.8 7 2.6 30-39 0 0.0 3 1.2 40-49 1 2.0 2 0.8 50-59 2 3.8 2 0.8 60-69 0 0.0 2 1.0 70+ 2 4.5 3 1.4 Total 6 1.6 27 1.5

c) Males


Age group 0-4 0 0.0 6 5.7 5-9 0 0.0 7 6.8 10-19 0 0.0 2 0.9 20-29 1 1.8 7 2.6 30-39 0 0.0 3 1.2 40-49 0 0.0 7 2.8 50-59 1 1.9 2 0.8 60-69 0 0.0 2 1.1 70+ 0 0.0 2 1.3 Total 2 0.5 38 2.1

TABLE 29: Frequency and age-specific rates (per 100,000 people), Shigellosis, by age group, WHR (2011-2016)


Total No. %

Month January 3 4.1 February 9 12.3 March 9 12.3 April 10 13.7 May 6 8.2 June 4 5.5 July 5 6.9 August 11 15.1 September 5 6.9 October 5 6.9 November 3 4.1 December 3 4.0

Number

Community area St. James-Assiniboia 2 Assiniboine South 4 Fort Garry 14 St. Vital 4 St. Boniface 9 Transcona 3 River East 8 Seven Oaks 2 Inkster 2 Point Douglas 1 Downtown 15 River Heights 9 Total 73

TABLE 30: Frequency and proportion, Shigellosis, by month, WHR (2011-2016)

TABLE 31: Frequency, Shigellosis, by community area, WHR (2011-2016)


TYPHOID FEVER

Number

2011 7 2012 6 2013 2 2014 2 2015 4 2016 5 Total 26

Table 32: Frequency, Typhoid Fever, WHR (2011-2016)


VEROTOXIGENIC E.COLI

FIGURE 22: Age-standardized rates (per 100,000 people), Verotoxigenic E.coli, WHR (2011-

2016)


a) Total


95%CI

2011 23 3.2 3.2 2.0 - 4.8 2012 17 2.4 2.4 1.4 - 3.8 2013 8 1.1 1.1 0.5 - 2.1 2014 14 1.9 1.9 1.0 - 3.2 2015 11 1.5 1.5 0.7 - 2.6 2016 19 2.6 2.6 1.5 - 4.0 Total 92 2.1 2.1 1.7 - 2.6

b) Females


95%CI

2011 13 3.6 3.5 1.8 - 6.0 2012 10 2.7 2.8 1.3 - 5.2 2013 5 1.3 1.3 0.4 - 3.1 2014 6 1.6 1.7 0.6 - 3.6 2015 4 1.1 1.1 0.3 - 2.8 2016 11 2.9 3.1 1.5 - 5.4 Total 49 2.2 2.2 1.6 - 2.9

c) Males


95%CI

2011 10 2.9 2.8 1.3 - 5.2 2012 7 2.0 2.0 0.8 - 4.2 2013 3 0.8 0.8 0.2 - 2.4 2014 8 2.2 2.2 0.9 - 4.2 2015 7 1.9 1.8 0.7 - 3.7 2016 8 2.2 2.1 0.9 - 4.1 Total 43 2.0 1.9 1.4 - 2.6

TABLE 33: Frequency, crude and age-standardized rates (per 100,000 people), Verotoxigenic

E.coli, WHR (2011-2016)


FIGURE 23: Age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group and

gender, WHR (2016)


a) Total


Age group 0-4 2 4.8 0.6 - 17.4 5-9 1 2.4 0.1 - 13.5 10-19 3 3.4 0.7 - 9.8 20-29 5 4.5 1.5 - 10.5 30-39 5 4.8 1.6 - 11.2 40-49 1 1.0 0.0 - 5.6 50-59 1 1.0 0.0 - 5.3 60-69 1 1.3 0.0 - 7.3 70+ 0 0.0 0.0 - 4.9 Total 19 2.6 1.5 - 4.0

b) Females


Age group 0-4 1 5.0 0.1 - 27.7 5-9 0 0.0 0.0 - 18.2 10-19 2 4.6 0.6 - 16.7 20-29 2 3.6 0.4 - 13.1 30-39 4 7.6 2.1 - 19.5 40-49 1 2.0 0.1 - 11.1 50-59 0 0.0 0.0 - 7.0 60-69 1 2.5 0.1 - 14.0 70+ 0 0.0 0.0 - 8.3 Total 11 2.9 1.5 - 5.2

c) Males


Age group 0-4 1 4.7 0.1 - 26.2 5-9 1 4.7 0.1 - 26.4 10-19 1 2.2 0.1 - 12.1 20-29 3 5.3 1.1 - 15.6 30-39 1 1.9 0.0 - 10.8 40-49 0 0.0 0.0 - 7.4 50-59 1 1.9 0.0 - 10.7 60-69 0 0.0 0.0 - 10.2 70+ 0 0.0 0.0 - 12.0 Total 8 2.2 0.9 - 4.3

TABLE 34: Frequency and age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age

group, WHR (2016)


FIGURE 24: Age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group and

gender, WHR (2011-2015)


a) Total


Age group 0-4 7 3.4 1.4 - 7.1 5-9 9 4.5 2.0 - 8.5 10-19 10 2.2 1.1 - 4.1 20-29 18 3.3 2.0 - 5.3 30-39 12 2.4 1.2 - 4.2 40-49 4 0.8 0.2 - 2.0 50-59 8 1.6 0.7 - 3.1 60-69 1 0.3 0.0 - 1.5 70+ 4 1.1 0.3 - 2.8 Total 73 2.0 1.6 - 2.5

b) Females


Age group 0-4 4 4.0 1.1 - 10.2 5-9 3 3.0 0.6 - 8.9 10-19 7 3.2 1.3 - 6.7 20-29 9 3.4 1.5 - 6.4 30-39 5 2.0 0.6 - 4.6 40-49 2 0.8 0.1 - 2.9 50-59 5 1.9 0.6 - 4.5 60-69 1 0.5 0.0 - 2.9 70+ 2 0.9 0.1 - 3.3 Total 38 2.0 1.4 - 2.8

c) Males


Age group 0-4 3 2.9 0.6 - 8.4 5-9 6 5.8 2.1 - 12.7 10-19 3 1.3 0.3 - 3.8 20-29 9 3.3 1.5 - 6.3 30-39 7 2.8 1.1 - 5.8 40-49 2 0.8 0.1 - 2.9 50-59 3 1.2 0.2 - 3.4 60-69 0 0.0 0.0 - 2.1 70+ 2 1.3 0.2 - 4.9 Total 35 2.0 1.4 - 2.7

TABLE 35: Frequency and age-specific rates (per 100,000 people), Verotoxigenic E.coli, by age group, WHR (2011-2015


2016 2011-2015 Total No. % No. % No. %


FIGURE 25: Frequency, Verotoxigenic E.coli, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 36: Frequency and proportion, Verotoxigenic E.coli, by month, WHR (2011-2016)




FIGURE 26: Age-standardized rates (per 100,000 people), Verotoxigenic E.coli, by community

area, WHR (2011-2016)

TABLE 37: Frequency, crude and age-standardized rates (per 100,000 people), Verotoxigenic

E.coli, by community area, WHR (2011-2016)


RESPIRATORY AND DIRECT CONTACT DISEASES This section of the report provides an overview of select diseases transmitted by direct contact or respiratory routes. A total of 433 cases fell under this category in the WHR between 2011 and 2016 representing a standardized rate of 9.9/100,000. The highest infection rates were observed in Downtown (23.7/100,000 people) and Point Douglas (22.7/100,000 people) CAs (Figure 27; Table 38).

FIGURE 27: Age-standardized rates (per 100,000 people), diseases transmitted by direct

contact and respiratory routes, by community area, WHR (2011-2016)



95%CI


TABLE 38: Frequency, crude and age-standardized rates (per 100,000 people), diseases

transmitted by direct contact or respiratory routes, by community area, WHR (2011-2016)


BLASTOMYCOSIS

Number Crude Rate

2011 0 0.0

2012 1 0.1

2013 0 0.0

2014 0 0.0

2015 0 0.0

2016 8 1.1

Total 9 0.2

CREUTZFELDT-JAKOB DISEASE

Number

year 2011 0 2012 0 2013 0 2014 3 2015 0 2016 1 Total 4

MENINGOCOCCAL INVASIVE DISEASE

Number

year 2011 1 2012 0 2013 4 2014 0 2015 1 2016 3 Total 9

TABLE 39: Frequency and crude rates (per 100,000 people), Blastomycosis, WHR (2011-2016)

TABLE 40: Frequency, Creutzfeldt - Jakob disease, WHR (2011-2016)

TABLE 41: Frequency, Meningococcal Invasive Disease, WHR (2011-2016)



INVASIVE PNEUMOCOCCAL

FIGURE 28: Age-standardized rates (per 100,000 people), Invasive Pneumococcal, WHR (2011-2016)


a) Total


95%CI

2011 78 11.0 10.9 8.6 - 13.6 2012 87 12.1 11.9 9.5 - 14.7 2013 57 7.8 7.6 5.8 - 9.9 2014 67 9.0 8.8 6.8 - 11.2 2015 53 7.1 7.2 5.4 - 9.4 2016 46 6.2 6.0 4.4 - 8.0 Total 388 8.8 8.7 7.9 - 9.6

b) Females


95%CI

2011 34 9.4 8.9 6.2 - 12.5 2012 53 14.4 14.0 10.5 - 18.4 2013 25 6.7 6.0 3.9 - 8.9 2014 31 8.2 7.9 5.4 - 11.3 2015 32 8.5 8.5 5.8 - 12.1 2016 25 6.6 6.3 4.1 - 9.4 Total 200 8.9 8.6 7.4 - 9.9

c) Males


95%CI

2011 44 12.7 12.9 9.4 - 17.4 2012 34 9.6 9.8 6.8 - 13.7 2013 32 8.9 9.0 6.2 - 12.7 2014 36 9.9 9.9 6.9 - 13.7 2015 21 5.7 6.0 3.7 - 9.2 2016 21 5.7 5.6 3.5 - 8.6 Total 188 8.7 8.8 7.6 - 10.2

TABLE 42: Frequency, crude and age-standardized rates (per 100,000 people), Invasive

Pneumococcal, WHR (2011-2016)


FIGURE 29: Age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group

and gender, WHR (2016)


a) Total


Age group 0-4 8 19.3 8.3 - 38.0 5-9 2 4.8 0.6 - 17.5 10-19 1 1.1 0.0 - 6.2 20-29 5 4.5 1.5 - 10.5 30-39 2 1.9 0.2 - 6.9 40-49 4 4.0 1.1 - 10.2 50-59 7 6.7 2.7 - 13.8 60-69 11 14.4 7.2 - 25.8 70+ 6 8.0 2.9 - 17.4 Total 46 6.2 4.5 - 8.3

b) Females


Age group 0-4 2 9.9 1.2 - 35.9 5-9 0 0.0 0.0 - 18.2 10-19 1 2.3 0.1 - 12.9 20-29 4 7.3 2.0 - 18.6 30-39 1 1.9 0.0 - 10.6 40-49 4 8.0 2.2 - 20.5 50-59 5 9.5 3.1 - 22.2 60-69 5 12.5 4.1 - 29.3 70+ 3 6.8 1.4 - 19.7 Total 25 6.6 4.3 - 9.8

c) Males


Age group 0-4 6 28.2 10.3 - 61.3 5-9 2 9.5 1.1 - 34.2 10-19 0 0.0 0.0 - 8.0 20-29 1 1.8 0.0 - 9.9 30-39 1 1.9 0.0 - 10.8 40-49 0 0.0 0.0 - 7.4 50-59 2 3.8 0.5 - 13.8 60-69 6 16.5 6.1 - 35.9 70+ 3 9.8 2.0 - 28.6 Total 21 5.7 3.6 - 8.8

TABLE 43: Frequency and age-specific rates (per 100,000 people), Invasive Pneumococcal, by

age group, WHR (2016)


FIGURE 30: Age-specific rates (per 100,000 people), Invasive Pneumococcal, by age group and gender, WHR (2011-2016)


a) Total


Age group

0-4 27 13.2 8.7 - 19.2 5-9 4 2.0 0.5 - 5.1 10-19 7 1.6 0.6 - 3.2 20-29 21 3.9 2.4 - 6.0 30-39 42 8.3 6.0 - 11.2 40-49 45 8.9 6.5 - 11.9 50-59 59 11.5 8.7 - 14.8 60-69 53 14.5 10.9 - 19.0 70+ 84 22.9 18.2 - 28.3 Total 342 9.4 8.4 - 10.4

b) Females


Age group

0-4 14 14.0 7.7 - 23.5 5-9 2 2.0 0.2 - 7.3 10-19 4 1.8 0.5 - 4.7 20-29 10 3.7 1.8 - 6.9 30-39 23 9.0 5.7 - 13.6 40-49 22 8.7 5.4 - 13.2 50-59 30 11.6 7.8 - 16.5 60-69 24 12.6 8.1 - 18.7 70+ 46 21.0 15.4 - 28.0 Total 175 9.4 8.1 - 10.9

c) Males


Age group

0-4 13 12.4 6.6 - 21.3 5-9 2 1.9 0.2 - 7.0 10-19 3 1.3 0.3 - 3.8 20-29 11 4.1 2.0 - 7.3 30-39 19 7.6 4.6 - 11.8 40-49 23 9.1 5.8 - 13.6 50-59 29 11.3 7.6 - 16.3 60-69 29 16.7 11.2 - 23.9 70+ 38 25.6 18.1 - 35.1 Total 167 9.3 8.0 - 10.9

TABLE 44: Frequency and age-specific rates (per 100,000 people), Invasive Pneumococcal, by

age group, WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 31: Frequency, Invasive Pneumococcal, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 45: Frequency and proportion, Invasive Pneumococcal, by community area, WHR

(2011-2016)




FIGURE 32: Age-standardized rates (per 100,000 people), Invasive Pneumococcal, by


TABLE 46: Frequency, crude and age-standardized rates (per 100,000 people), Invasive

Pneumococcal, by community area, WHR (2011-2016)


VACCINE PREVENTABLE DISEASES This section of the report provides an overview of select diseases that are preventable by routine immunization. A total of 264 cases fell under this category between 2009 and 2014 in the WHR. The highest rate was observed in Point Douglas (11.8/100,000 people).

FIGURE 33: Age-standardized rates (per 100,000 people), vaccine preventable diseases, by





TABLE 47: Frequency, crude and age-standardized rates (per 100,000 people), vaccine

preventable diseases, by community area, WHR (2011-2016)


DIPHTHERIA

Number

year 2011 1 2012 0 2013 1 2014 0 2015 4 2016 3 Total 9

HAEMOPHILUS INFLUENZAE NON-SEROTYPE B INVASIVE DISEASE

Number

year 2011 9 2012 5 2013 6 2014 8 2015 5 2016 4 Total 37

TABLE 48: Frequency, Diphtheria, WHR (2011-2016)

TABLE 49: Frequency, Haemophilus influenzae non-serotype B invasive disease, WHR (2011-

2016)


HEPATITIS B

a) Total

Number Crude Rate

2011 7 1.0

2012 2 0.3

2013 2 0.3

2014 1 0.1

2015 7 0.9

2016 13 1.7

Total 32 0.7

b) Females

Number Crude Rate

2011 1 0.3

2012 1 0.3

2013 0 0.0

2014 1 0.3

2015 2 0.5

2016 3 0.8

Total 8 0.4

c) Males

Number Crude Rate

2011 6 1.7

2012 1 0.3

2013 2 0.6

2014 0 0.0

2015 5 1.4

2016 10 2.7

Total 24 1.1

TABLE 50: Frequency and crude rates (per 100,000 people), Hepatitis B, WHR (2011-2016)


a) Total

2016 2011-2015


Age group 0-4 0 0.0 0 0.0 5-9 0 0.0 0 0.0 10-19 0 0.0 1 0.2 20-29 2 1.8 2 0.4 30-39 5 4.8 6 1.2 40-49 5 5.0 2 0.4 50-59 1 1.0 5 1.0 60-69 0 0.0 2 0.5 70+ 0 0.0 1 0.3 Total 13 1.7 19 0.5

b) Females


Age group 0-4 0 0.0 0 0.0 5-9 0 0.0 0 0.0 10-19 0 0.0 0 0.0 20-29 1 1.8 1 0.4 30-39 1 1.9 1 0.4 40-49 1 2.0 0 0.0 50-59 0 0.0 2 0.8 60-69 0 0.0 1 0.5 70+ 0 0.0 0 0.0 Total 3 0.8 5 0.3

c) Males


Age group 0-4 0 0.0 0 0.0 5-9 0 0.0 0 0.0 10-19 0 0.0 1 0.4 20-29 1 1.8 1 0.4 30-39 4 7.8 5 2.0 40-49 4 8.0 2 0.8 50-59 1 1.9 3 1.2 60-69 0 0.0 1 0.6 70+ 0 0.0 1 0.7 Total 10 2.7 14 0.8

TABLE 51: Frequency and age-specific rates (per 100,000 people), Hepatitis B, by age group,

WHR (2011-2016)


Total No. %

Month January 1 3.1

February 2 6.3

March 1 3.1

April 1 3.1

May 5 15.6

June 5 15.6

July 1 3.1

August 4 12.5

September 4 12.5

October 2 6.3

November 4 12.5

December 2 6.3

Number

Community area St. James 2 Assiniboine South 1 Fort Garry 2 St. Vital 1 St. Boniface 0 Transcona 1 River East 3 Seven Oaks 2 Inkster 1 Point Douglas 10 Downtown 8 River Heights 1 Total 32

TABLE 52: Frequency and proportion, Hepatitis B, by month, WHR (2011-2016)

Table 53: Frequency, Hepatitis B, by community area, WHR (2011-2016)


MUMPS

FIGURE 34: Age-standardized rates (per 100,000 people), Mumps, WHR (2011-2016)


a) Total


2011 2 0.3 0.3 0.0 - 1.1 2012 6 0.8 0.8 0.3 - 1.8 2013 1 0.1 0.1 0.0 - 0.8 2014 0 0.0 0.0 0.0 - 0.5 2015 3 0.4 0.4 0.1 - 1.1 2016 89 12.0 11.3 9.1 - 14.0 Total 101 2.3 2.2 1.8 - 2.7

b) Females


2011 0 0.0 0.0 0.0 - 1.0 2012 4 1.1 1.1 0.3 - 2.8 2013 0 0.0 0.0 0.0 - 1.0 2014 0 0.0 0.0 0.0 - 1.0 2015 2 0.5 0.5 0.1 - 1.7 2016 33 8.7 8.8 6.0 - 12.3 Total 39 1.7 1.7 1.2 - 2.4

c) Males


2011 2 0.6 0.6 0.1 - 2.1 2012 2 0.6 0.6 0.1 - 2.0 2013 1 0.3 0.3 0.0 - 1.6 2014 0 0.0 0.0 0.0 - 1.0 2015 1 0.3 0.3 0.0 - 1.6 2016 56 15.3 13.8 10.4 - 18.0 Total 62 2.9 2.6 2.0 - 3.4

TABLE 54: Frequency, crude and age-standardized rates (per 100,000 people), Mumps, WHR (2011-2016)


FIGURE 35: Age-specific rates (per 100,000 people), Mumps, by age group and gender, WHR

(2016)


a) Total


Age group 0-4 0 0.0 0.0 - 8.9 5-9 0 0.0 0.0 - 8.9 10-19 20 22.4 13.7 - 34.6 20-29 55 49.5 37.3 - 34.4 30-39 10 9.6 4.6 - 17.7 40-49 3 3.0 0.6 - 8.8 50-59 1 1.0 0.0 - 5.3 60-69 0 0.0 0.0 - 4.8 70+ 0 0.0 0.0 - 4.9 Total 89 12.0 9.6 - 14.7

b) Females


Age group 0-4 0 0.0 0.0 - 18.3 5-9 0 0.0 0.0 - 18.2 10-19 9 20.8 9.5 - 39.5 20-29 16 29.1 16.6 - 47.2 30-39 5 9.5 3.1 - 22.3 40-49 3 6.0 1.2 - 17.5 50-59 0 0.0 0.0 - 7.0 60-69 0 0.0 0.0 - 9.2 70+ 0 0.0 0.0 - 8.3 Total 33 8.7 6.0 - 12.3

c) Males


Age group 0-4 0 0.0 0.0 - 17.3 5-9 0 0.0 0.0 - 17.5 10-19 11 23.9 11.9 - 42.8 20-29 39 69.5 49.4 - 95.0 30-39 5 9.7 3.1 - 22.6 40-49 0 0.0 0.0 - 7.4 50-59 1 1.9 0.0 - 10.7 60-69 0 0.0 0.0 - 10.2 70+ 0 0.0 0.0 - 12.0 Total 56 15.3 11.6 - 19.9

TABLE 55: Frequency and age-specific rates (per 100,000 people), Mumps, by age group,

WHR (2016)


FIGURE 36: Age-specific rates (per 100,000 people), Mumps, by age group and gender, WHR

(2011-2015)


a) Total


Age group

0-4 0 0.0 0.0 - 1.8 5-9 0 0.0 0.0 - 1.8 10-19 3 0.7 0.1 - 2.0 20-29 2 0.4 0.0 - 1.3 30-39 3 0.6 0.1 - 1.7 40-49 1 0.2 0.0 - 1.1 50-59 2 0.4 0.0 - 1.4 60-69 0 0.0 0.0 - 1.0 70+ 1 0.3 0.0 - 1.5 Total 12 0.3 0.2 - 0.6

b) Females


Age group

0-4 0 0.0 0.0 - 3.7 5-9 0 0.0 0.0 - 3.7 10-19 1 0.5 0.0 - 2.6 20-29 2 0.7 0.1 - 2.7 30-39 1 0.4 0.0 - 2.2 40-49 0 0.0 0.0 - 1.5 50-59 1 0.4 0.0 - 2.2 60-69 0 0.0 0.0 - 1.9 70+ 1 0.5 0.0 - 2.5 Total 6 0.3 0.1 - 0.7

c) Males


Age group

0-4 0 0.0 0.0 - 3.5 5-9 0 0.0 0.0 - 3.6 10-19 2 0.9 0.1 - 3.1 20-29 0 0.0 0.0 - 1.4 30-39 2 0.8 0.1 - 2.9 40-49 1 0.4 0.0 - 2.2 50-59 1 0.4 0.0 - 2.2 60-69 0 0.0 0.0 - 2.1 70+ 0 0.0 0.0 - 2.5 Total 6 0.3 0.1 - 0.7

TABLE 56: Frequency and age-specific rates (per 100,000 people), Mumps, by age group,

WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 37: Frequency, Mumps, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 57: Frequency and proportion, Mumps, by month, WHR (2011-2016)




FIGURE 38: Age-standardized rates (per 100,000 people), Mumps, by community area, WHR

(2011-2016)

TABLE 58: Frequency, crude and age-standardized rates (per 100,000 people), Mumps, by



PERTUSSIS

FIGURE 39: Age-standardized rates (per 100,000 people), Pertussis, WHR (2011-2016)


a) Total


2011 7 1.0 0.9 0.4 - 1.9 2012 18 2.5 2.5 1.5 - 3.9 2013 1 0.1 0.1 0.0 - 0.7 2014 5 0.7 0.7 0.2 - 1.6 2015 5 0.7 0.6 0.2 - 1.5 2016 36 4.8 4.8 3.4 - 6.6 Total 72 1.6 1.6 1.3 - 2.0

b) Females


2011 4 1.1 1.1 0.3 - 2.8 2012 7 1.9 2.0 0.8 - 4.1 2013 0 0.0 0.0 0.0 - 1.0 2014 3 0.8 0.8 0.2 - 2.3 2015 3 0.8 0.8 0.2 - 2.3 2016 20 5.3 5.5 3.3 - 8.4 Total 37 1.7 1.7 1.2 - 2.3

c) Males


2011 3 0.9 0.8 0.2 - 2.4 2012 11 3.1 2.9 1.5 - 5.3 2013 1 0.3 0.3 0.0 - 1.5 2014 2 0.5 0.5 0.1 - 1.9 2015 2 0.5 0.5 0.1 - 1.9 2016 16 4.4 4.2 2.4 - 6.8 Total 35 1.6 1.5 1.1 - 2.1

TABLE 59: Frequency, crude and age-standardized rates (per 100,000 people), Pertussis, WHR (2011-2016)


FIGURE 40: Age-specific rates (per 100,000 people), Pertussis, by age group and gender, WHR

(2016)


a) Total


Age group 0-4 24 57.9 37.1 - 86.2 5-9 1 2.4 0.1 - 13.5 10-19 7 7.8 3.2 - 16.2 20-29 0 0.0 0.0 - 3.3 30-39 0 0.0 0.0 - 3.5 40-49 1 1.0 0.0 - 5.6 50-59 2 1.9 0.2 - 6.9 60-69 1 1.3 0.0 - 7.3 70+ 0 0.0 0.0 - 4.9 Total 36 4.8 3.4 - 6.7

b) Females


Age group 0-4 14 69.5 38.0 - 116.6 5-9 1 4.9 0.1 - 27.5 10-19 4 9.2 2.5 - 23.7 20-29 0 0.0 0.0 - 6.7 30-39 0 0.0 0.0 - 7.0 40-49 0 0.0 0.0 - 7.4 50-59 0 0.0 0.0 - 7.0 60-69 1 2.5 0.1 - 14.0 70+ 0 0.0 0.0 - 8.3 Total 20 5.3 3.2 - 8.2

c) Males


Age group 0-4 10 46.9 22.5 - 86.3 5-9 0 0.0 0.0 - 17.5 10-19 3 6.5 1.3 - 19.0 20-29 0 0.0 0.0 - 6.6 30-39 0 0.0 0.0 - 7.2 40-49 1 2.0 0.1 - 11.1 50-59 2 3.8 0.5 - 13.8 60-69 0 0.0 0.0 - 10.2 70+ 0 0.0 0.0 - 12.0 Total 16 4.4 2.5 - 7.1

TABLE 60: Frequency and age-specific rates (per 100,000 people), Pertussis, by age group, WHR (2016)


FIGURE 41: Age-specific rates (per 100,000 people), Pertussis, by age group and gender, WHR

(2011-2015)


a) Total


Age group 0-4 25 12.2 7.9 - 18.0 5-9 3 1.5 0.3 - 4.3 10-19 4 0.9 0.2 - 2.3 20-29 3 0.6 0.1 - 1.6 30-39 1 0.2 0.0 - 1.1 40-49 0 0.0 0.0 - 0.7 50-59 0 0.0 0.0 - 0.7 60-69 0 0.0 0.0 - 1.0 70+ 0 0.0 0.0 - 1.0 Total 36 1.0 0.7 - 1.4

b) Females


Age group 0-4 11 11.0 5.5 - 19.7 5-9 1 1.0 0.0 - 5.6 10-19 2 0.9 0.1 - 3.3 20-29 2 0.7 0.1 - 2.7 30-39 1 0.4 0.0 - 2.2 40-49 0 0.0 0.0 - 1.5 50-59 0 0.0 0.0 - 1.4 60-69 0 0.0 0.0 - 1.9 70+ 0 0.0 0.0 - 1.7 Total 17 0.9 0.5 - 1.5

c) Males


Age group 0-4 14 13.4 7.3 - 22.5 5-9 2 1.9 0.2 - 7.0 10-19 2 0.9 0.1 - 3.1 20-29 1 0.4 0.0 - 2.1 30-39 0 0.0 0.0 - 1.5 40-49 0 0.0 0.0 - 1.5 50-59 0 0.0 0.0 - 1.4 60-69 0 0.0 0.0 - 2.1 70+ 0 0.0 0.0 - 2.5 Total 19 1.1 0.6 - 1.7

TABLE 61: Frequency and age-specific rates (per 100,000 people), Pertussis, by age group,

WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 42: Frequency, Pertussis, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 62: Frequency and proportion, Pertussis, by month, WHR (2011-2016)




FIGURE 43: Age-standardized rates (per 100,000 people), Pertussis, by community area, WHR

(2011-2016)

Table 63: Frequency, crude and age-standardized rates (per 100,000 people), Pertussis, by



RUBELLA

Number

Year 2011 1 2012 1 2013 0 2014 0 2015 1 2016 2 Total 5

TABLE 64: Frequency, Rubella, WHR (2011-2016)


VECTORBORNE AND ZOONOTIC DISEASES This section of the report provides an overview of select diseases transmitted by insects and animals. A total of 202 cases fell under this category in the WHR between 2011 and 2016 representing a standardized rate of 4.6/100,000 people. The highest infection rates were observed in the Downtown (7.5/100,000 people) and St. Boniface (7.0/100,000 people) community areas (Figure 44; Table 65).

FIGURE 44: Age-standardized rates (per 100,000 people), vectorborne and zoonotic diseases,

by community area, WHR (2011-2016)


Number Crude Rate

Age-Standardized Rate 95%CI


TABLE 65: Frequency, crude and age-standardized rates (per 100,000 people) by community

area, vectorborne and zoonotic diseases, WHR (2011-2016)


ANAPLASMOSIS

Number

Year 2011 - 2012 - 2013 - 2014 - 2015 4 2016 3 Total 7

BRUCELLOSIS

Number

year 2011 1 2012 0 2013 1 2014 0 2015 0 2016 1 Total 3

TABLE 66: Frequency, Anaplasmosis, WHR (2011-2016)

TABLE 67: Frequency, Brucellosis, WHR (2011-2016)


LYME

FIGURE 45: Age-standardized rates (per 100,000 people), Lyme, WHR (2011-2016)


a) Total


2011 1 0.1 0.1 0.0 - 0.8 2012 7 1.0 1.0 0.4 - 2.0 2013 11 1.5 1.5 0.7 - 2.7 2014 14 1.9 1.8 1.0 - 3.1 2015 12 1.6 1.6 0.9 - 2.9 2016 17 2.3 2.3 1.3 - 3.7 Total 62 1.4 1.4 1.1 - 1.8

b) Females


2011 0 0.0 0.0 0.0 - 1.0 2012 1 0.3 0.3 0.0 - 1.5 2013 6 1.6 1.6 0.6 - 3.4 2014 2 0.5 0.5 0.1 - 2.0 2015 1 0.3 0.3 0.0 - 1.5 2016 6 1.6 1.7 0.6 - 3.6 Total 16 0.7 0.7 0.4 - 1.2

c) Males


2011 1 0.3 0.3 0.0 - 1.6 2012 6 1.7 1.7 0.6 - 3.8 2013 5 1.4 1.5 0.5 - 3.4 2014 12 3.3 3.2 1.7 - 5.7 2015 11 3.0 3.1 1.5 - 5.5 2016 11 3.0 3.0 1.5 - 5.4 Total 46 2.1 2.2 1.6 - 2.9

TABLE 68: Frequency, crude and age-standardized rates (per 100,000 people), Lyme, WHR

(2011-2016)


FIGURE 46: Age-specific rates (per 100,000 people), Lyme, by age group and gender, WHR

(2016)


a) Total


Age group 0-4 0 0.0 0.0 - 8.9 5-9 1 2.4 0.1 - 13.5 10-19 5 5.6 1.8 - 13.0 20-29 1 0.9 0.0 - 5.0 30-39 2 1.9 0.2 - 6.9 40-49 0 0.0 0.0 - 3.7 50-59 2 1.9 0.2 - 6.9 60-69 6 7.9 2.9 - 17.1 70+ 0 0.0 0.0 - 4.9 Total 17 2.3 1.3 - 3.7

b) Females


Age group 0-4 0 0.0 0.0 - 18.3 5-9 0 0.0 0.0 - 18.2 10-19 3 6.9 1.4 - 20.3 20-29 0 0.0 0.0 - 6.7 30-39 1 1.9 0.0 - 10.6 40-49 0 0.0 0.0 - 7.4 50-59 0 0.0 0.0 - 7.0 60-69 2 5.0 0.6 - 18.1 70+ 0 0.0 0.0 - 8.3 Total 6 1.6 0.6 - 3.5

c) Males


Age group 0-4 0 0.0 0.0 - 17.3 5-9 1 4.7 0.1 - 26.4 10-19 2 4.3 0.5 - 15.7 20-29 1 1.8 0.0 - 9.9 30-39 1 1.9 0.0 - 10.8 40-49 0 0.0 0.0 - 7.4 50-59 2 3.8 0.5 - 13.8 60-69 4 11.0 3.0 - 28.2 70+ 0 0.0 0.0 - 12.0 Total 11 3.0 1.5 - 5.4

TABLE 69: Frequency and age-specific rates (per 100,000 people), Lyme, by age group, WHR

(2016)


FIGURE 47: Age-specific rates (per 100,000 people), Lyme, by age group and gender, WHR (2011-2015)


a) Total


Age group 0-4 1 0.5 0.0 - 2.7 5-9 1 0.5 0.0 - 2.8 10-19 4 0.9 0.2 - 2.3 20-29 3 0.6 0.1 - 1.6 30-39 6 1.2 0.4 - 2.6 40-49 7 1.4 0.6 - 2.8 50-59 6 1.2 0.4 - 2.5 60-69 12 3.3 1.7 - 5.8 70+ 5 1.4 0.4 - 3.2 Total 45 1.2 0.9 - 1.6

b) Females


Age group 0-4 0 0.0 0.0 - 3.7 5-9 1 1.0 0.0 - 5.6 10-19 1 0.5 0.0 - 2.6 20-29 0 0.0 0.0 - 1.4 30-39 1 0.4 0.0 - 2.2 40-49 1 0.4 0.0 - 2.2 50-59 2 0.8 0.1 - 2.8 60-69 4 2.1 0.6 - 5.4 70+ 0 0.0 0.0 - 1.7 Total 10 0.5 0.3 - 1.0

c) Males


Age group 0-4 1 1.0 0.0 - 5.3 5-9 0 0.0 0.0 - 3.6 10-19 3 1.3 0.3 - 3.8 20-29 3 1.1 0.2 - 3.2 30-39 5 2.0 0.6 - 4.7 40-49 6 2.4 0.9 - 5.2 50-59 4 1.6 0.4 - 4.0 60-69 8 4.6 2.0 - 9.1 70+ 5 3.4 1.1 - 7.8 Total 35 2.0 1.4 - 2.7

TABLE 70: Frequency and age-specific rates (per 100,000 people), Lyme, by age group, WHR

(2011-2015)


2016 2011-2015 Total No. % No. % No. %


FIGURE 48: Frequency, Lyme, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 71: Frequency and proportion, Lyme, by month, WHR (2011-2016)




FIGURE 49: Age-standardized rates (per 100,000 people), Lyme, by community area, WHR

(2011-2016)

TABLE 72: Frequency, crude and age-standardized rates (per 100,000 people), Lyme, by



MALARIA

FIGURE 50: Age-standardized rates (per 100,000 people), Malaria, WHR (2011-2016)


a) Total


2011 19 2.7 2.7 1.6 - 4.2 2012 13 1.8 1.8 1.0 - 3.1 2013 11 1.5 1.5 0.8 - 2.7 2014 18 2.4 2.4 1.4 - 3.9 2015 18 2.4 2.5 1.5 - 3.9 2016 16 2.2 2.1 1.2 - 3.4 Total 95 2.2 2.2 1.8 - 2.7

b) Females


2011 6 1.7 1.7 0.6 - 3.7 2012 5 1.4 1.4 0.4 - 3.2 2013 2 0.5 0.6 0.1 - 2.0 2014 3 0.8 0.8 0.2 - 2.4 2015 2 0.5 0.6 0.1 - 2.1 2016 4 1.1 1.0 0.3 - 2.5 Total 22 1.0 1.0 0.6 - 1.5

c) Males


2011 13 3.7 3.7 2.0 - 6.3 2012 8 2.3 2.2 0.9 - 4.4 2013 9 2.5 2.5 1.1 - 4.7 2014 15 4.1 4.0 2.3 - 6.7 2015 16 4.4 4.3 2.5 - 7.0 2016 12 3.3 3.1 1.6 - 5.5 Total 73 3.4 3.3 2.6 - 4.2

TABLE 73: Frequency, crude and age-standardized rates (per 100,000 people), Malaria, WHR (2011-2016)


FIGURE 51: Age-specific rates (per 100,000 people), Malaria, by age group and gender,

WHR (2016)


a) Total


Age group 0-4 5 12.1 3.9 - 28.2 5-9 0 0.0 0.0 - 8.9 10-19 2 2.2 0.3 - 8.1 20-29 5 4.5 1.5 - 10.5 30-39 1 1.0 0.0 - 5.4 40-49 1 1.0 0.0 - 5.6 50-59 2 1.9 0.2 - 6.9 60-69 0 0.0 0.0 - 4.8 70+ 0 0.0 0.0 - 4.9 Total 16 2.2 1.2 - 3.5

b) Females


Age group 0-4 1 5.0 0.1 - 27.7 5-9 0 0.0 0.0 - 18.2 10-19 0 0.0 0.0 - 8.5 20-29 3 5.5 1.1 - 15.9 30-39 0 0.0 0.0 - 7.0 40-49 0 0.0 0.0 - 7.4 50-59 0 0.0 0.0 - 7.0 60-69 0 0.0 0.0 - 9.2 70+ 0 0.0 0.0 - 8.3 Total 4 1.1 0.3 - 2.7

c) Males


Age group 0-4 4 18.8 5.1 - 48.1 5-9 0 0.0 0.0 - 17.5 10-19 2 4.3 0.5 - 15.7 20-29 2 3.6 0.4 - 12.9 30-39 1 1.9 0.0 - 10.8 40-49 1 2.0 0.1 - 11.1 50-59 2 3.8 0.5 - 13.8 60-69 0 0.0 0.0 - 10.2 70+ 0 0.0 0.0 - 12.0 Total 12 3.3 1.7 - 5.7

TABLE 74: Frequency and age-specific rates (per 100,000 people), Malaria, by age group,

WHR (2016)


FIGURE 52: Age-specific rates (per 100,000 people), Malaria, by age group and

gender, WHR (2011-2016)


a) Total


Age group 0-4 6 2.9 1.1 - 6.4 5-9 4 2.0 0.5 - 5.1 10-19 13 2.9 1.6 - 5.0 20-29 16 3.0 1.7 - 4.8 30-39 14 2.8 1.5 - 4.7 40-49 16 3.2 1.8 - 5.1 50-59 9 1.7 0.8 - 3.3 60-69 0 0.0 0.0 - 1.0 70+ 1 0.3 0.0 - 1.5 Total 79 2.2 1.7 - 2.7

b) Females


Age group 0-4 2 2.0 0.2 - 7.2 5-9 1 1.0 0.0 - 5.6 10-19 3 1.4 0.3 - 4.1 20-29 2 0.7 0.1 - 2.7 30-39 4 1.6 0.4 - 4.0 40-49 4 1.6 0.4 - 4.0 50-59 1 0.4 0.0 - 2.2 60-69 0 0.0 0.0 - 1.9 70+ 1 0.5 0.0 - 2.5 Total 18 1.0 0.6 - 1.5

c) Males


Age group 0-4 4 3.8 1.0 - 9.8 5-9 3 2.9 0.6 - 8.5 10-19 10 4.4 2.1 - 8.0 20-29 14 5.2 2.8 - 8.7 30-39 10 4.0 1.9 - 7.3 40-49 12 4.7 2.4 - 8.3 50-59 8 3.1 1.3 - 6.2 60-69 0 0.0 0.0 - 2.1 70+ 0 0.0 0.0 - 2.5 Total 61 3.4 2.6 - 4.4

TABLE 75: Frequency and age-specific rates (per 100,000 people), Malaria, by age

group, WHR (2011-2015)


2016 2011-2015 Total No. % No. % No. %

Month January 3 18.8 5 6.3 8 8.4 February 0 0.0 6 7.6 6 6.3 March 0 0.0 5 6.3 5 5.3 April 0 0.0 1 1.3 1 1.1 May 4 25.0 12 15.2 16 16.8 June 1 6.3 8 10.1 9 9.5 July 1 6.3 3 3.8 4 4.2 August 3 18.8 10 12.7 13 13.7 September 2 12.5 12 15.2 14 14.7 October 0 0.0 7 8.9 7 7.4 November 0 0.0 6 7.6 6 6.3

December 2 12.5 4 5.1 6 6.3

FIGURE 53: Frequency, Malaria, by month, WHR (2016 vs. 2011-2015 mean)

TABLE 76: Frequency and proportion, Malaria, by month, WHR (2011-2016)




FIGURE 54: Age-standardized rates (per 100,000 people), Malaria, by community area, WHR

(2011-2016)

TABLE 77: Frequency, crude and age-standardized rates (per 100,000 people), Malaria, by community area, WHR (2011-2016)


WEST NILE VIRUS

Number Crude Rate

2011 0 0.0

2012 13 1.8

2013 2 0.3

2014 1 0.1

2015 2 0.3

2016 8 1.1

Total 26 0.6

TABLE 78: Frequency and crude rates (per 100,000 people), West Nile Virus,

WHR (2011-2016)


EMERGING INFECTIOUS DISEASES

This section of the report provides an overview of emerging infectious diseases that are being

monitored in the WHR. For this report, emerging infectious diseases include newly identified

species, new/evolved strains of a known infection, or known infections that are occurring in a

new population or new geographic region. In 2016, Zika Virus was the only emerging infectious

disease under surveillance in the region.

Zika Virus

In 2016, there were six laboratory-confirmed cases of Zika Virus in the WHR for a rate of 0.8 cases per 100,000 people. The mean age of cases was 38 years old (minimum 18, maximum 46).


APPENDICES

APPENDIX A – Common and technical names of reportable diseases under The Manitoba Public Health Act

Common name Scientific or technical name of disease or its

infectious agent Included

Rational for exclusion

AIDS Acquired Immunodeficiency syndrome X

Not captured in iPHIS

Amebiasis Entamoeba histolytica √

Anaplasmosis (human granulocytic anaplasmosis)

Anaplasma phagocytophilum √

Anthrax Bacillus anthrasis √

Babesiosis Babesia species √

Benign tumour of the brain or central nervous system

Benign tumour of the brain or central nervous system X


Blastomycosis Blastomyces dermatitidis √

Botulism Clostridium botulinum √

Brucellosis Brucella species √

Campylobacteriosis Camplylobacter species √

Cancer or malignant neoplasm Cancer or malignant neoplasm X


Chancroid Haemophilus ducreyi X


Chlamydia Chlamydia trachomatis (including LGV) X


Cholera Vibrio cholerae, subgroup O1 O139 or other toxigenic only √

Clostridium difficile associated diarrhea

Clostridium difficile toxin X


Congenital Rubella Infection/Syndrome

Rubella virus √

Creutzfeldt-Jakob Disease, Classic and Variant

Creutzfeldt-Jakob Disease prion √

Cryptosporidiosis Cryptosporidium species √

Cyclospora Cyclospora cayetanensis √

Diphtheria

toxin-producing Corynebacterium species: Dipheriae, ulcerans, pseudotuberculosis √

Giardiasis Giardia lamblia, intestinalis, duodenalis √

Gonorrhea Neisseria gonorrhoaea X


+Haemophilus influenzae Haemophilus influenzae √





Serotype B Invasive Disease (serotype B)

+Haemophilus influenzae non-Serotype B Invasive Disease

Haemophilus influenzae (non serotype B) √

Hantavirus Pulmonary Syndrome

Hantavirus √

Hepatitis A Hepatitis A virus √

Hepatitis B Hepatitis B virus √

Hepatitis C Hepatitis C virus X


HIV Human Immunodeficiency virus X


Influenza, Laboratory Confirmed Influenza virus X

Reported elsewhere

Legionellosis Legionella species √

Leprosy Mycobacterium leprae √

Listeriosis invasive disease Listeria monocytogenes in normally sterile tissue √

Lyme Disease Borrelia burgdorferi √

Malaria Plasmodium species √

Measles Measles virus √

Meningococcal invasive disease Neisseria meningitidis √

Mumps Mumps virus √ Pertussis Bordetella pertussis √

Plague Yersinia pestis √

Pneumococcal Disease, Invasive Streptococcus pneumoniae √

Poliomyelitis Poliovirus √

Q fever Coxiella burnetii √

Rabies Rabies virus √

Rubella Rubella virus √

Salmonellosis Salmonella species, excluding S. typhi √

Severe Acute Respiratory Infection (SARI)

Severe Acute Respiratory Infection √

Shigellosis Shigella species √

Smallpox Variola major & minor virus √

Streptococcal Invasive Disease (Group A)

Streptococcus pyogenes √

Streptococcal Invasive Disease of the newborn (Group B)

Streptococcus agalactiae √

Syphilis (All categories) Treponema pallidum pallidum X


Tetanus Clostridium tetani √

Tuberculosis Mycobacterium X Reported





tuberculosis, africanum, canetti, caprae, microti, pinnipedi, bovis

elsewhere

Tularemia Francisella tularensis √

Typhoid Fever Salmonella typhi √

Verotoxigenic Escherichia coli infection

Verotoxin-producing strains of E.coli √

Viral Hemorrhagic Fever Crimean Congo, Lassa, Ebola, Marburg, Rift Valley √

West Nile Virus (WNV) West Nile Virus √

Yellow Fever Yellow Fever Virus √

WRHA THE EPIDEMIOLOGY OF COMMUNICABLE DISEASES IN THE WINNIPEG HEALTH REGION 128 WRHA WINIPEG HEALTH REGION INJURY REPORT, 2000–2010 1

200-2010 PUBLISHED MARCH 2014

Documents

2011-2016 - Winnipeg Regional Health Authority · management of reportable ... Communicable Disease Coordinators: public health nursing leadership, ... Amebiasis, WHR (2011-2016)